US20090226549A1 - Herbal extracts and flavor systems for oral products and methods of making the same - Google Patents

Herbal extracts and flavor systems for oral products and methods of making the same Download PDF

Info

Publication number
US20090226549A1
US20090226549A1 US12/399,295 US39929509A US2009226549A1 US 20090226549 A1 US20090226549 A1 US 20090226549A1 US 39929509 A US39929509 A US 39929509A US 2009226549 A1 US2009226549 A1 US 2009226549A1
Authority
US
United States
Prior art keywords
flavor
flavor system
less
herbal extract
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/399,295
Inventor
Kenneth John Hughes
Sylvia Gaysinsky
Roger Michael Browning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sensient Flavors LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/399,295 priority Critical patent/US20090226549A1/en
Assigned to SENSIENT FLAVORS LLC reassignment SENSIENT FLAVORS LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HUGHES, KENNETH JOHN, BROWNING, ROGER MICHAEL, GAYSINSKY, SYLVIA
Publication of US20090226549A1 publication Critical patent/US20090226549A1/en
Priority to US13/490,206 priority patent/US11211249B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/235Foeniculum (fennel)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer
    • H01L21/18Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic System or AIIIBV compounds with or without impurities, e.g. doping materials
    • H01L21/22Diffusion of impurity materials, e.g. doping materials, electrode materials, into or out of a semiconductor body, or between semiconductor regions; Interactions between two or more impurities; Redistribution of impurities
    • H01L21/223Diffusion of impurity materials, e.g. doping materials, electrode materials, into or out of a semiconductor body, or between semiconductor regions; Interactions between two or more impurities; Redistribution of impurities using diffusion into or out of a solid from or into a gaseous phase
    • H01L21/2236Diffusion of impurity materials, e.g. doping materials, electrode materials, into or out of a semiconductor body, or between semiconductor regions; Interactions between two or more impurities; Redistribution of impurities using diffusion into or out of a solid from or into a gaseous phase from or into a plasma phase
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer
    • H01L21/18Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic System or AIIIBV compounds with or without impurities, e.g. doping materials
    • H01L21/26Bombardment with radiation
    • H01L21/263Bombardment with radiation with high-energy radiation
    • H01L21/265Bombardment with radiation with high-energy radiation producing ion implantation
    • H01L21/26506Bombardment with radiation with high-energy radiation producing ion implantation in group IV semiconductors
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer
    • H01L21/18Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic System or AIIIBV compounds with or without impurities, e.g. doping materials
    • H01L21/26Bombardment with radiation
    • H01L21/263Bombardment with radiation with high-energy radiation
    • H01L21/265Bombardment with radiation with high-energy radiation producing ion implantation
    • H01L21/2658Bombardment with radiation with high-energy radiation producing ion implantation of a molecular ion, e.g. decaborane
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L29/00Semiconductor devices adapted for rectifying, amplifying, oscillating or switching, or capacitors or resistors with at least one potential-jump barrier or surface barrier, e.g. PN junction depletion layer or carrier concentration layer; Details of semiconductor bodies or of electrodes thereof  ; Multistep manufacturing processes therefor
    • H01L29/66Types of semiconductor device ; Multistep manufacturing processes therefor
    • H01L29/66007Multistep manufacturing processes
    • H01L29/66075Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials
    • H01L29/66227Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials the devices being controllable only by the electric current supplied or the electric potential applied, to an electrode which does not carry the current to be rectified, amplified or switched, e.g. three-terminal devices
    • H01L29/66409Unipolar field-effect transistors
    • H01L29/66477Unipolar field-effect transistors with an insulated gate, i.e. MISFET
    • H01L29/66568Lateral single gate silicon transistors
    • H01L29/66575Lateral single gate silicon transistors where the source and drain or source and drain extensions are self-aligned to the sides of the gate
    • H01L29/6659Lateral single gate silicon transistors where the source and drain or source and drain extensions are self-aligned to the sides of the gate with both lightly doped source and drain extensions and source and drain self-aligned to the sides of the gate, e.g. lightly doped drain [LDD] MOSFET, double diffused drain [DDD] MOSFET
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L29/00Semiconductor devices adapted for rectifying, amplifying, oscillating or switching, or capacitors or resistors with at least one potential-jump barrier or surface barrier, e.g. PN junction depletion layer or carrier concentration layer; Details of semiconductor bodies or of electrodes thereof  ; Multistep manufacturing processes therefor
    • H01L29/66Types of semiconductor device ; Multistep manufacturing processes therefor
    • H01L29/68Types of semiconductor device ; Multistep manufacturing processes therefor controllable by only the electric current supplied, or only the electric potential applied, to an electrode which does not carry the current to be rectified, amplified or switched
    • H01L29/76Unipolar devices, e.g. field effect transistors
    • H01L29/772Field effect transistors
    • H01L29/78Field effect transistors with field effect produced by an insulated gate
    • H01L29/7833Field effect transistors with field effect produced by an insulated gate with lightly doped drain or source extension, e.g. LDD MOSFET's; DDD MOSFET's
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer
    • H01L21/18Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic System or AIIIBV compounds with or without impurities, e.g. doping materials
    • H01L21/26Bombardment with radiation
    • H01L21/263Bombardment with radiation with high-energy radiation
    • H01L21/265Bombardment with radiation with high-energy radiation producing ion implantation
    • H01L21/26506Bombardment with radiation with high-energy radiation producing ion implantation in group IV semiconductors
    • H01L21/26513Bombardment with radiation with high-energy radiation producing ion implantation in group IV semiconductors of electrically active species

Definitions

  • the present invention provides a method of producing an herbal extract and also a flavor system that can provide both antimicrobial benefits with pleasant organoleptic properties for use in oral products.
  • the invention provides a method for preparing an herbal extract including (1) treating an herb with a low temperature liquid CO 2 extraction in the presence of an alcohol to produce an alcohol-herb extract; (2) distilling the alcohol-herb extract to remove at least a portion of the alcohol and produce a first herbal extract; and (3) molecularly distilling the first herbal extract to produce a second herbal extract.
  • the invention provides a flavor system including an herbal extract produced by the above process.
  • the invention provides a flavor system including an herbal extract comprising thymol, eugenol, carvacrol and eucalyptol.
  • the invention provides a flavor system comprising a thyme extract having a minimum inhibitory concentration for at least one of Porphyromonas gingivalis, Actinomycess viscosus, Actinomyces naeslundii, Streptococcus mutans , and Fusobacterium nucleatum , and the minimum inhibitory concentration is less than about 3%.
  • the invention provides an oral product comprising one of the flavor systems of the present invention.
  • FIG. 1 is a schematic diagram of a system to extract an herbal extract, including treating an herb to a low temperature liquid CO 2 extraction process in the presence of ethanol.
  • FIG. 2 is a schematic diagram of a liquid CO 2 -alcohol extraction process.
  • FIG. 3 is a schematic diagram of a process to remove alcohol from an alcohol-herbal extract resulting from a liquid CO 2 -alcohol extraction process, using low vacuum distillation.
  • FIG. 4 is a schematic diagram of a molecular distillation process to produce a final herbal extract that is a concentrated distillate.
  • FIG. 5 is a graph of percent release of Marker 1, thymol, and Marker 2, menthol, from chewing gum versus time, to monitor flavor release.
  • any numerical range recited herein includes all values from the lower value to the upper value. For example, if a concentration range is stated as 1% to 50%, it is intended that values such as 2% to 40%, 10% to 30%, or 1% to 3%, etc., are expressly enumerated in this specification. These are only examples of what is specifically intended, and all possible combinations of numerical values between and including the lowest value and the highest value enumerated are to be considered to be expressly stated in this application.
  • the invention provides a process of making an herbal extract.
  • the herbal extract may be derived from thyme, oregano, cilantro, ginger, lavender, allspice, basil, bay, celery seed, pimento, lemongrass, parsley, onion, mustard, tarragon, sage, rosemary, coriander, marjoram, cumin, fennel, cinnamon, clove, black peppercorn and the like.
  • One particularly suitable herbal extract comprises thyme.
  • the herbal extract comprises a mixture of compounds, both active and inactive in providing antimicrobial efficacy and flavor.
  • the invention provides a process that produces a thyme extract with unique flavoring, coloring, and antimicrobial properties.
  • the process generally includes the following: 1) a first low temperature liquid CO 2 -alcohol extraction process; 2) a low vacuum distillation process; and 3) a molecular distillation process.
  • the combination of these steps provides a highly concentrated, low color, high flavor and antimicrobial activity herbal extract.
  • the invention also provides a flavor system for the addition to compositions of oral products such as toothpaste, mouth rinse, gums, lozenges, and the like.
  • the flavor system comprises an herbal extract.
  • the flavor system may also include at least one characterizing flavor component, such as a flavor oil.
  • the flavor system may include a second characterizing flavor component, such as menthol crystals.
  • One suitable embodiment of the flavor system comprises thyme extract, peppermint oil and menthol crystals.
  • the compositions are suitably non-toxic and have antimicrobial activity.
  • the invention provides a flavor system that provides antimicrobial activity, wherein the antimicrobial activity is measured by a minimum inhibitory concentration.
  • the flavor system comprises an herbal extract, and has a minimum inhibitory concentration that is less than about 3%, less than about 2%, less than about 1%, less than about 0.5%, less than about 0.3%, less than about 0.2%, less than about 0.1%, less than about 0.05% for at least one of Porphyromonas gingivalis, Actinomyces viscosus, Actinomycess naeslundii, Streptococcus mutans , and Fusobacterium nucleatum.
  • the invention provides an oral composition having antimicrobial activity, the oral composition comprising a flavor system including an herbal extract and at least one characterizing flavor component.
  • the invention provides a method for producing an herbal extract.
  • the method comprises 1) extracting an alcohol-herbal extract from the herb using a liquid CO 2 -alcohol extraction at temperatures less than about 25° C.; 2) distilling the alcohol-herbal extract under vacuum to remove at least a portion of the alcohol and produce a first herbal extract; and 3) molecularly distilling the first herbal extract to produce a second herbal extract.
  • the first step includes treating the herb to a low temperature liquid CO 2 extraction process in the presence of ethanol. This process is illustrated in FIG. 1 and FIG. 2 .
  • Dry herbs ( 1 ) are milled on a hammermill with an about 1 millimeter to about 7 millimeter screen to increase the surface area and rupture the herb.
  • the herb is blended with at least about 10%, at least about 15%, at least about 20%, at least about 25%, or at least about 30% of its own weight of de-ionized water, using a ribbon mixer or similar equipment until homogenous, e.g., about 5 minutes.
  • the dampened herb material ( 1 ) is packed into a series of extraction columns ( 20 ). The columns are treated by dynamic flow of liquid carbon dioxide ( 10 ) injected with alcohol ( 11 ) as a co-extraction entrainer.
  • the amount of CO 2 -alcohol used can be measured as a mean flow rate through the extraction column.
  • Suitable flow rates include at least about 150 kg/hr, at least about 175 kg/hr, at least about 200 kg/hr, at least about 222 kg/hr, or at least about 240 kg/hr.
  • the flow rate may be less than about 350 kg/hr, less than about 325 kg/hr, less than about 300 kg/hr, less than about 275 kg/hr, or less than about 260 kg/hr.
  • the ratio of CO 2 to alcohol may vary according to the herb being processed.
  • the alcohol is provided in at least about 0.1%, at least about 0.2%, at least about 0.3%, at least about 0.5%, at least about 0.7%, at least about 1.0%, or at least about 2.0% by weight in the liquid CO 2 .
  • the alcohol is provided at a mean flow rate of 1 kg/hr with the CO 2 provided at a mean flow rate of 250 kg/hr.
  • the alcohol is ethanol.
  • the CO 2 -alcohol is provided to the extraction columns under pressure, the pressure being at least about 35 atmosphere, at least about 40 atmosphere, at least about 45 atmosphere, at least about 50 atmosphere, at least about 55 atmosphere, or at least about 60 atmosphere, wherein a suitable range is about 45-55 atmosphere.
  • the process is driven by an approximately 10 atmosphere differential within the plant during operation.
  • this process is carried out at temperatures that are less than about 25° C., less than about 20° C., less than about 15° C., less than about 12° C.
  • the temperature may be between about 0° C. and about 10° C.
  • the temperature is about 7° C. ⁇ 1° C. These temperatures are below the temperatures used in supercritical CO 2 extraction which occur above the critical temperature 31° C., and more typically at 40-60° C., and very often higher.
  • the lower temperatures concentrate more of the volatile components in the extract and avoid the decomposition of components.
  • the liquid CO 2 phase extraction is more selective for more volatile components and therefore achieves higher concentrations of them.
  • the liquefied carbon dioxide-alcohol is a unique solvent mixture that dissolves the low molecular weight organoleptically active components of the herb.
  • the low temperature and pressurized system prevents the degradation and loss of volatiles which may typically occur with a traditional essential oil distillation process, while higher molecular weight unwanted materials such as heavier fats, waxes, pigments, sugars, starches and tannins are excluded by this extraction process.
  • the CO 2 -alcohol-herb extract solution emerging from the extraction columns is passed to a heat exchanger ( 21 ) where the temperature is raised a few degrees within the closed system, and the CO 2 is changed to vapor by the change in temperature and removed via pipe work to the compressor for recycling to liquid CO 2 through the process.
  • the alcohol-extract is collected from the system as a cold foam product, and as the foam warms to room temperature any residual CO 2 vaporizes and leaves the alcohol-herbal extract ( 2 ).
  • the time of extraction depends on the material used and can be readily determined by one of ordinary skill in the art. For a thyme extract, the extraction time per extraction column filled with thyme leaves (about at least 25 kg, more suitably 28 kg) is at least about 4 hours.
  • FIG. 2 charts a description of the CO 2 -alcohol extraction process in detail.
  • Liquid CO 2 1 enters the system into a liquid CO 2 holding tank 2 .
  • the CO 2 is processed through a heat exchanger 3 and a refrigeration unit 4 to provide the liquid CO 2 at the desired temperature of about 7° C.
  • the liquid CO 2 is injected with alcohol from an alcohol storage tank 6 via a co-entainer pump 7 .
  • the liquid CO 2 -alcohol solvent is pumped through a set of extraction columns 8 A-E which hold the milled herbal leaves.
  • the liquid CO 2 -alcohol -herbal extract is processed through the heat exchanger 3 (giving an initial input of energy into the extract) to an automatic mixing valve 9 , an automatic flow control valve 10 and filters 11 into a main condenser-heat exchanger 12 where the CO 2 is recycled back into the CO 2 holding tank 2 and the product is collected via the product collection pump 17 to a product tap 18 .
  • CO 2 is also purified to be reused and recovered from the condenser-heat exchanger 12 through a demisting filter 13 , a compressor 14 , a de-oil misting filter 15 and at a vapor temperature control 16 .
  • a vaporizer 19 pumps warm vapor back into the extraction columns 8 .
  • a second step of the process includes processing the alcohol-herbal extract from the extraction through a low vacuum distillation process to remove the alcohol as depicted in FIG. 3 and form a first herbal extract ( 3 ).
  • This process can be carried out using a suitable vacuum still ( 23 ).
  • the alcohol is removed under low vacuum distillation at typically a temperature of at least about 20° C., at least about 30° C., at least about 35° C., at least about 40° C., at least about 45° C., at least about 50° C., at least about 55° C., or at least about 60° C., one suitable range is between about 30 to about 40° C., finishing at a maximum of about at least 60° C., to reduce the alcohol content to a residual level.
  • Residual alcohol may be less than about 25%, less than about 20%, less than about 15%, or less than about 10%.
  • the residual alcohol may be at least about 0.05%, at least about 0.1%, at least about 0.2%, at least about 0.5%, at least about 1%, at least about 2%, or at least about 5%.
  • a third step of the process includes a molecular distillation process.
  • a falling-film short path still may be used. Suitable stills such as models KD5 or KD10 Molecular Stills are available from UIC GmbH of Germany. This step of the process is depicted in FIG. 4 .
  • This special design of the still subjects the material being processed to heating for the briefest possible time while allowing a very high vacuum to be achieved, lowering the vaporizing temperature and thus greatly limiting the overall exposure of the extract.
  • the liquid extract ( 3 ) is continuously feed into the still ( 40 ) and passes down the inside of a heated jacket ( 28 ), which is at about at least 80° C., at least about 90° C., or at least about 100° C., as a thin film produced by the centrifugal force of the rotating rollers ( 27 ), and falls by gravity to be collected.
  • This process is carried out under high vacuum conditions, wherein the pressure is suitably at least about 5 ⁇ 10 ⁇ 4 mbar, at least about 1 ⁇ 10 ⁇ 3 mbar, at least about 1.5 ⁇ 10 ⁇ 3 mbar, or at least about 2 ⁇ 10 ⁇ 3 mbar.
  • the pressure is suitably at least less than about 1 ⁇ 10 ⁇ 2 mbar, less than about 5 ⁇ 10 ⁇ 2 mbar, less than about 7 ⁇ 10 ⁇ 2 mbar, or less than about 1 ⁇ 10 ⁇ 3 .
  • the extract is subjected to heat typically for only a few minutes.
  • the extract passes through the system at a rate of about at least 1 kg/hr, at least about 2 kg/hr, at least about 3 kg/hr, at least about 5 kg/hr, at least about 7 kg/hr, at least about 8 kg/hr, or at least about 10 kg/hr.
  • the rate is about 1 to about 2 kg/hr for a KD10 Molecular Still.
  • the volatile material passes as a laminar flow of vapor across a very short path onto a condenser ( 30 ) which is concentric at the center of the roller assembly, and falls by gravity into a receiver.
  • This laminar flow coupled with the use of high efficiency rotary and oil diffusion vacuum pumps and a liquid nitrogen trap at ⁇ 200° C. allows vacuum pressures down to 10 ⁇ 6 atmosphere to be achieved.
  • Materials in the extract that would be damaged or even decomposed during traditional distillation are separated and purified into the final herbal extract. This process produces a second herbal extract ( 4 ) that is a concentrated distillate with reduced color.
  • the invention also provides a flavor system comprising the herbal extract.
  • the herbal extract is suitably provided as at least about 1% wt/wt, at least about 2% wt/wt, at least about 4% wt/wt, at least about 6% wt/wt, at least about 9% wt/wt, at least about 15% wt/wt, at least about 20% wt/wt, or at least about 25% wt/wt of the flavor system.
  • the thyme extract is suitably provided as less than about 30% wt/wt, less than about 20% wt/wt, less than about 15% wt/wt, less than about 12% wt/wt of the flavor system.
  • One suitable herbal extract is a thyme extract derived from dry thyme by the process described above.
  • the thyme extract is a mixture of compounds, both active and inactive in providing antimicrobial efficacy and flavor. Suitable processes produce thyme extract with unique flavoring and antimicrobial properties.
  • This thyme extract has unique and beneficial properties from thyme oils produced by other known methods.
  • the main active ingredients of the thyme extract that provide antimicrobial efficacy include thymol, eugenol, carvacrol and eucalyptol.
  • Thyme extract also includes a number of inactive ingredients, some of which can be found in Table 7.
  • the unique chemical composition of this extract provides the unique flavor, color and antimicrobial properties.
  • the thyme extract provides a more appealing flavor in addition to antimicrobial benefits.
  • THYME TEMPLARTM available from Sensient Flavors, Inc. (Indianapolis, Ind.).
  • the flavor system may also include at least one characterizing flavor component that provides organoleptic properties of pleasant taste and smell, and may provide additional antimicrobial activity as well.
  • a first characterizing flavor component may constitute suitably at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 47%, at least about 50%, at least about 60%, or at least about 70% wt/wt of the flavor system.
  • the first characterizing flavor component may constitute less than about 70% wt/wt, less than about 60% wt/wt, less than about 55% wt/wt, less than about 50% wt/wt, less than about 40% wt/wt, or less than about 20% wt/wt of the flavor system.
  • the first characterizing flavor component may be a flavor oil. Examples of flavor oils that may be used include, but are not limited to, peppermint oil, spearmint oil, oil of wintergreen, lavender oil, rosemary oil, clove oil and cinnamon oil.
  • the flavor system may also include a second characterizing flavor component.
  • the flavor system may suitably includes at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50% wt/wt, at least about 60% wt/wt, or at least about 70% wt/wt of the secondary flavor component.
  • the flavor system may suitably include less than about 70%, less than about 60%, less than about 50%, less than about 40%, less than about 30%, less than about 20%, less than about 15%, or less than about 10% of the secondary flavor component.
  • a secondary flavor component includes, but is not limited to, menthol crystals, C 10 H 20 O, which are an organic compound made synthetically or obtained from mint oils, most commonly produced from Mentha arvensis .
  • Menthol is a waxy, clear or white crystalline substance commercially available from Monarchy Aromatics, Ltd.
  • first and second characterizing flavor components may be from oils, crystals, liquid concentrates, synthetic flavors, or combinations thereof. Additional characterizing flavor components may include, but are not limited to, oils derived from plants and fruit such as citrus oils, fruit essences, peppermint oil, spearmint oil, other mint oils, clove oil, oil of wintergreen, cinnamon, anise, artificial flavoring agents such aldehyde flavors including, but are not limited to, acetaldehyde (apple), benzaldehyde (cherry, almond), anisic aldehyde (licorice, anise), cinnamic aldehyde (cinnamon), citral, i.e., alpha citral (lemon, lime), neral, i.e., beta citral (lemon, lime), decanal (orange, lemon), ethyl vanillin (vanilla, cream), heliotropine, i.e., piperonal (vanilla, cream), vanillin (vanilla), van
  • the invention also provides a flavor system comprising an herbal extract.
  • Antimicrobial activity is the ability of an herbal extract to retard the growth of and/or prevent the growth of oral bacteria.
  • Examples of representative gram-positive and gram-negative oral bacteria include, but are not limited to, Actinmoyces viscosus Actinomyces naeslundii, Fusobacteriumm nucleatum, Porphyromonas gingivalis, Streptococcus mutans , and Streptococcus sanguis .
  • Anti-microbial activity can be measured by the minimum inhibitory concentration of the agent.
  • the minimum inhibitory concentration of an herbal extract is the concentration of the extract within a test sample at which no bacterial growth is observed.
  • the test sample may be saliva or a suitable bacterial culture. In the examples below, the minimum inhibitory concentration is provided as a percentage.
  • the minimum inhibitory concentration for the herbal extract is measured as a percent volume (e.g., 1% would be one part flavor system in 99 parts test sample) as described in the example below.
  • the herbal extract may provide antimicrobial activity as measured by minimum inhibitory concentration (MIC) of at least about 0.01%, at least about 0.05%, at least about 0.1%, at least about 0.2%, at least about 0.5% for an oral bacteria.
  • the herbal extract may provide antimicrobial activity as measured by minimum inhibitory concentration of less than about 5%, less than about 3%, less than about 2%, less than about 1%, less than about 0.5%, less than about 0.3%, less than about 0.2%, less than about 0.1% for an oral bacterial.
  • the flavor system may include additional antimicrobial agents.
  • Suitable antimicrobial agents include, but are not limited to, cedarwood oil, chloramphenicol, berberine, Glycyrrhiza glabra extract, juicy fruit basil oil, juniper berries oil, lemon basil oil, orally active metallic ion such as salts of zinc, tin, silver and copper, hexylresorcinol, cetylpyridinium chloride, chlorhexidine digluconate, 5-chloro-2-(2,4-dichlorophenoxy)-phenol, commonly referred to as triclosan, phthalic acid and its salts including, but not limited to those disclosed in U.S. Pat. No.
  • TPC tetradecylpyridinium chloride
  • TDEPC N-tetradecyl-4-ethyllpyridinium chloride
  • octenidine delmopinol, octapinol, and other piperidino derivatives
  • niacin preparations zinc/stannous ion agents
  • antibiotics such as augmentin, amoxicillin, tetracycline, doxycycline, minocycline, and metronidazole
  • analogs and salts of the above essential oils including thymol, geraniol, carvacrol, citral, hinokitiol, eucalyptol, catechol (particularly 4-allyl catechol) and mixtures thereof; methyl salicylate; hydrogen peroxide; metal salts of chlorite and mixtures of all of the above.
  • TPC tetradecylpyridinium chloride
  • TDEPC N-tetradecyl-4-ethyllpyridinium
  • Sweeteners may also be included in the flavor system. Suitable sugar sweeteners include, but are not limited to, sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, glucose, galactose, corn syrup solids, stevioside, Lo-Han Guo, and the like, alone or in combination. Sugarless sweeteners include, but are not limited to, sugar alcohols such as sorbitol, mannitol, xylitol, hydrogenated starch hydrolysates, maltitose, and the like, alone or in combination. High intensity artificial sweeteners can also be used alone or in combination with other sweeteners.
  • sweeteners include, but are not limited to, sucralose, aspartame, MAPM derivatives such as neotame, salts of acesulfame, altitame, saccharin and its salts, cyclamic acid and its salts, glycyrrhizinate, dihydrochalcones, thaumatin, monellin, and the like, alone or in combination.
  • the flavor systems are manufactured by mixing a first characterizing flavor component (e.g., peppermint oil) with a second characterizing flavor component (e.g., menthol crystals) and heating the mixture to at least about 35° C., to at least about 40° C., to at least about 45° C., to at least about 50° C., to at least about 55° C., to at least about 60° C., to at least about 65° C. until the second characterizing flavor component is melted in a standard mixer. The mixture is mixed until homogenous and then cooled. The thyme extract is added to the mixture and mixed until homogenous.
  • a first characterizing flavor component e.g., peppermint oil
  • a second characterizing flavor component e.g., menthol crystals
  • the thyme extract may be added to a first characterizing flavor component without the use of a second flavoring component and mixed until homogenous.
  • the thyme extract and first characterizing flavor component may be mixed at room temperature. Other flavors may also be added and mixed until homogenous.
  • the flavor systems may be used in the preparation of spray dried flavor compositions.
  • the flavor systems may be combined with encapsulating agents such as the starch-based encapsulating agent Hi-Cap 100 from National Starch (Bridgewater, N.J., U.S.A.) and water.
  • suitable encapsulating agents may include N-Lok® 1930, CAPSUL®, CAPSUL®TA (all from National Starch), and EmCapTM (from Cargill, Inc., Cedar Rapids, Iowa, U.S.A.).
  • the water and starch-based encapsulating agent may be mixed, and a flavor system may be added to the starch and water mixture to form an emulsion.
  • the emulsion may be dried with an inlet temperature of about 160° C.
  • the encapsulating agent may be present in amounts of at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, or at least about 50% by weight of the total spray dried flavor composition.
  • the encapsulating agent may be present in a suitable amount less than about 50%, less than about 40%, less than about 20%, less than about 10%, or less than about 5% by weight of spray dried flavor composition.
  • the flavor system may be added to amounts of at least about 0.5%, at least about 0.8%, at least about 1%, at least about 2%, at least about 4%, at least about 6%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, or at least about 70% by weight of the total spray dried flavor composition.
  • the flavor system may be used in the composition in a suitable amount less than about 60%, less than about 50%, less than about 20%, less than about 12%, less than about 10%, less than about 7%, less than about 5%, less than about 3%, or less than about 2% by weight of spray dried flavor composition.
  • the spray dried flavor formulations may be used with or without other flavor systems and may be incorporated into compositions such as water, chewing gums, toothpaste, mouth rinse, liquid dentifrice, lozenges, liquid spray, and edible films.
  • the flavor systems may be used in the preparation of oral compositions for oral products by the addition of the flavor system at amounts of at least about 0.5%, at least about 0.8%, at least about 1%, at least about 2%, at least about 4%, at least about 6%, at least about 10% by weight of the total oral composition.
  • the flavor system may be used in the oral composition in a suitable amount less than about 20%, less than about 12%, less than about 10%, less than about 7%, less than about 5%, less than about 3%, less than about 2% by weight of the oral composition.
  • Oral compositions may be products which in the ordinary course of usage are not intentionally swallowed for purposes of systemic administration of particular therapeutics agents, but are rather retained in the oral cavity for a time sufficient to contact substantially all the dental surfaces and/or oral tissues for purposes of oral activity.
  • Methods of preparing the oral compositions may include mixing the flavor system by conventional methods to an oral delivery agent.
  • Oral delivery agents include, but are not limited to, a toothpaste, mouth rinse, liquid dentifrice, gum, lozenges, liquid spray, and edible films. Toothpaste may be paste or gel formulations unless otherwise specified. The amount of flavor system added depends on the particular oral composition to which it is added.
  • chewing gums may include at least about 0.5%, more suitably at least about 2% wt/wt of flavor system while edible oral films may comprise at least about 6%, more suitable at least about 10% wt/wt of the flavor system due to their very low weight.
  • the oral compositions comprise a sufficient amount of the flavor system to provide antimicrobial activity.
  • the oral compositions may include sweeteners as described above. Further, the oral compositions may include other antimicrobial agents.
  • the oral compositions may also contain other flavoring agents, if desired.
  • the flavoring agents may include essential oils, synthetic flavors or mixtures thereof including, but not limited to, oils derived from plants and fruits, such as citrus oils, fruit essences, peppermint oil, spearmint oil, other mint oils, clove oil, oil of wintergreen, anise and the like. Artificial flavoring agents and components may also be used. Natural and artificial flavoring agents may be combined in any sensorially acceptable fashion. Flavoring may include a cooling agent to enhance the flavor and perceived freshness.
  • the oral compositions may be chewing gums or any variation including but not limited to bubble gums, pellets, gum balls or sticks. Chewing gums may be coated or not coated and be of a variety of flavors, shapes and sizes.
  • a chewing gum composition includes a gum base, and a suitable amount of the flavor system as described above. Chewing gum may be manufactured by any suitable conventional method.
  • the base for the chewing gum includes an elastomer of a type normally employed in chewing gums, e.g., chicle, gum, jelutong, balata, crown gum, gutta-percha, sorva, butadiene-styrene copolymer, polyisobutylene, isobutylene-isoprene copolymer, polyethylene, and the like or mixtures thereof.
  • Softeners may be added to chewing gum in order to optimize the chewability and mouth-feel of the gum.
  • Chewing gums may include at least about 0.1%, at least about 0.5%, at least about 1%, at least about 2% of the flavor system.
  • Chewing gums may include less than about 3%, less than about 2.5%, less than about 2% of the flavor system.
  • Dry thyme leaves were milled on a hammermill with a 3 millimeter screen to increase the surface area and rupture the leaves.
  • 28 kg of dry milled thyme leaves were added to 8.4 kg of water and mixed in a ribbon mixer until homogenous, about 5 minutes.
  • the moistened thyme leaves were added to a stainless steel extraction column.
  • Each extraction column was loaded with 28 kg dry thyme leaves.
  • Three extraction columns were used.
  • Liquid CO 2 was injected with 1 kg/hr of ethanol (96A % natural fermentation grade), the CO 2 provided to the extractor at a rate of 250 kg/hr for 4 hours per extraction column under 45 atmosphere pressure at 7° C. ⁇ 1°.
  • the CO 2 -ethanol-thyme extract was collected and passed through a heat exchanger which vaporizes the CO 2 to produce an ethanol-thyme extract to yield about 17% the weight of the initial leaves at this stage.
  • the ethanol-thyme extract was processed by low vacuum distillation at 35° C. at 200 mbar to remove the ethanol in a batch still.
  • the distilled thyme-extract was then treated on a thin-film molecular distillation unit (KD5 model, UIC GmbH of Germany) under vacuum pressure of 10 ⁇ 6 atmospheres at 100° C. at a flow rate of 1 kg per hour.
  • the thyme extract was analyzed by mass spectroscopy and an exemplary list of the chemical composition of the thyme extract is shown in Table 1.
  • Thyme extract Compound % Ethanol 5.03 Acetic Acid 0.349 1-octen-3-ol 1.031 p-cymene 6.382 Eucalyptol 0.43 Linalool 2.354 Camphor 0.232 Boreol 1.423 4-terpineol 0.542 thymol methyl ether 0.701 carvacrol methyl ether 1.141 Thymol 58.468 Carvacrol 4.436 Eugenol 0.589 beta-caryophyllene 1.326 caryophyllene oxide 0.794 Total 85.228
  • a flavor system was formulated using the components set forth in Table 2.
  • the peppermint oil and menthol crystals were added together in a standard mixer and heated to 113° F. and mixed until homogenous. The mixture was then cooled and the thyme extract and natural thymol were added and mixed until homogenous.
  • a flavor system formulation was prepared using the following formulation in Table 3.
  • the peppermint oil and menthol crystals were added together in a standard mixer, heated to 113° F. until the menthol crystals dissolved, and the mixture was cooled. The thyme extract was then added to the mixture and mixed until homogeneous.
  • a batch of flavor system formulation C was analyzed by gas chromatography/mass spectrometry (GC/MS) using standard methods providing the main chemical composition of formulation C as shown in Table 4.
  • GC/MS gas chromatography/mass spectrometry
  • a flavor system formulation was prepared as described in Example 3 but using the following formulation in Table 5.
  • a batch of flavor system of formulation D was analyzed as described in Example 3.
  • the formulation of the main chemical compositions of formula D can be found in Table 6.
  • Chewing gum compositions are prepared by incorporating the flavor systems of Examples 3 and 4 with a chewing gum (Trident gum manufactured by Cadbury Adams located in Parsippany N.J.). The flavor systems are added at 2% weight of the composition of the gum.
  • Liquid filled chewing gum compositions are prepared by incorporating the flavor systems of Examples 3 and 4, the liquid portion of Dentyne Ice gum filling is mixed with 0.1% of the flavor system and the solid portion of the Dentyne Ice gum base is mixed with 3% of the flavor system.
  • Liquid filled chewing gum compositions are prepared by incorporating the flavor systems of Examples 3 and 4, the liquid portion of Dentyne Ice gum filling is mixed with 1.0% of the flavor system and the solid portion of the Dentyne Ice gum base is mixed with 3% of the flavor system.
  • Mouth rinse compositions are prepared by mixing 2% by weight of the flavor systems of Examples 3 and 4 with a mouth rinse.
  • Toothpaste compositions are prepared by mixing 2% of flavor systems of Examples 3 and 4 with unflavored toothpaste until the mixture is homogenous.
  • Edible film compositions are prepared by mixing 10% by weight of the flavor systems of Examples 3 and 4 with a substance to form an edible film.
  • composition of the thyme extract (THYME TEMPLARTM) obtained by ethanol CO 2 extraction process was analyzed as described in Example 3.
  • An exemplary list of the chemical composition is shown in Table 7.
  • the four flavor systems were provided in an undiluted form and each flavor system was diluted to the working test solutions of 1.0%, 0.5%, 0.05%, and 0.001% (v/v) flavor system.
  • Each testing system had a final volume of 2.0 ml, each containing at least 1 ⁇ 10 6 bacteria, adequate amount of the flavor system to obtain the working test solution, 1 ml of double strength enriched trypticase-soy broth and saline solution to bring the final volume up to 2 ml.
  • Each test was run in triplicate.
  • Each testing sample was vigorously vortexed for 30 to 60 seconds to enhance physical contact of the bacteria with the relatively insoluble test products.
  • a 1.0 ml aliquot was taken and placed into a flask containing 250 ml of Trypticase Soy Broth (TSB) supplemented with 0.25% (w/v) glucose.
  • Flasks containing Porphyromonas gingivalis or Fusobacterium nucleatum were incubated at 37° C. in an anaerobic chamber (85% N 2 —10% CO 2 —5% H 2 ), while the other bacteria flasks were incubated at 37° C. in ambient air. Samples were evaluated after 24 hours.
  • the minimal inhibitory concentration (MIC) was determined as the test sample with the greatest dilution that exhibited no bacteria growth (e.g., remained clear, not turbid).
  • MIC scores for each of the flavor systems for each of the bacteria tested are shown in Table 8.
  • Flavor FN AN AV PG SM A 0.05% 0.05% 0.05% ⁇ 0.01% 0.05% B 0.05% 0.1% 0.5% 0.05% 0.5% C 0.05% 0.5% 0.1% 0.05% 0.1% D 0.1% 0.1% 0.5% 0.05% 1%
  • Example 5 To test if adequate flavor is released from chewing gum, the chewing gums made in Example 5 were tested using a mechanical instrument to simulate human mastication of chewing gum, which can be found in Kleber et al. A mastication device designed for the evaluation of chewing gum is set forth in Journal of Dental Research, 1981, 109-114, which is incorporated herein in its entirety. Artificial saliva (15 ml) was placed in the reservoir, and the thermostatically controlled heating element was turned on to maintain the saliva and gum at body temperature for proper chewing consistency. One stick of test chewing gum (approximately 3 grams with 2% flavor system added) was placed in the warmed chamber and the artificial saliva was exposed to the chewing gum for 1 minute under chewing simulation conditions.
  • FIG. 5 shows release of the two markers at different predetermined times. Based on marker release, it was estimated that most of the flavor was released for Marker 2 between 5 and 10 minutes of chewing. Marker 1 was released constantly for the first 10 minutes and afterward decreases. Marker 2 was released at 55% in flavor C and flavor D while 40.8% and 33% of Marker 1 was released from flavor C and D respectively. It was estimated that enough flavor was released during the first 15-20 minutes to have antimicrobial activity based on the quantity released and the MIC results.
  • Dry thyme leaves were milled on a hammermill with a 3 millimeter screen to increase the surface area and rupture the leaves.
  • 28 kg of dry milled thyme leaves were added to 8.4 kg of water and mixed in a ribbon mixer until homogenous, about 5 minutes.
  • the moistened thyme leaves were added to a stainless steel extraction column.
  • Each extraction column was loaded with 28 kg dry thyme leaves.
  • Three extraction columns were used.
  • Liquid CO 2 was injected with 1 kg/hr of ethanol (96A % natural fermentation grade), the CO 2 provided to the extractor at a rate of 250 kg/hr for 4 hours per extraction column under 45 atmosphere pressure at 7° C. ⁇ 1°.
  • the CO 2 -ethanol-thyme extract was collected and passed through a heat exchanger which vaporizes the CO 2 to produce an ethanol-thyme extract to yield about 17% the weight of the initial leaves at this stage.
  • the ethanol-thyme extract was processed by low vacuum distillation at 35° C. at 200 mbar to remove the ethanol in a batch still.
  • the distilled thyme-extract was then treated on a thin-film molecular still (KD5 model, UIC GmbH of Germany) under vacuum pressure of 10 ⁇ 6 atmospheres at 100° C. at a flow rate of 1 kg per hour.
  • An anti-microbial spray dried flavor formulation was prepared by mixing water and a starch-based encapsulating agent such as Hi-Cap 100 (National Starch, Bridgewater, N.J., U.S.A.).
  • Hi-Cap 100 National Starch, Bridgewater, N.J., U.S.A.
  • An oil flavor system was prepared as described in Example 3 except with the formulation according to Table 9. The oil flavor system was added to the starch and water to form an emulsion at a concentration of 16% (wt/wt) flavor system, 24% (wt/wt) Hi-Cap 100, and 60% (wt/wt) water with an average particle size of about 0.5 ⁇ m. The emulsion was then spray dried with an inlet temperature of about 160° C.
  • the final spray dried formulation was made into a volatile oil composition and analyzed with GC-MS.
  • the chemical composition is shown in Table 10. Encapsulation of the flavor system removed water and some (about 20-60%) of the volatile oils from the formulation, resulting in about 40% load encapsulation.
  • the anti-microbial spray dried flavor formulation may be incorporated into compositions such as water, chewing gums, toothpaste, mouth rinse, liquid dentifrice, lozenges, liquid spray, and edible films.
  • a breath freshening spray dried flavor formulation was prepared by mixing water and a starch-based encapsulating agent such as Hi-Cap 100 (National Starch, Bridgewater, N.J., U.S.A.).
  • a starch-based encapsulating agent such as Hi-Cap 100 (National Starch, Bridgewater, N.J., U.S.A.).
  • the oil flavor system as prepared and described in Example 3 (5% THYME TEMPLARTM, 40% menthol crystals, 55% peppermint oil) was added to the starch and water mixture to form an emulsion at a concentration of 16% (wt/wt) flavor system, 24% (wt/wt) Hi-Cap 100, and 60% (wt/wt) water with an average particle size of about 0.5 ⁇ m.
  • the emulsion was then spray dried with an inlet temperature of about 160° C.
  • the final spray dried formulation was made into a volatile oil composition and analyzed with GC-MS.
  • the chemical composition is shown in Table 11. Encapsulation of the flavor system removed water and some (about 20-60%) of the volatile oils from the formulation, resulting in about 40% load encapsulation.
  • the breath freshening spray dried formulation may be incorporated into compositions such as water, chewing gums, toothpaste, mouth rinse, liquid dentifrice, lozenges, liquid spray, and edible films.

Abstract

The invention provides a method for preparing an herbal extract and a flavor system comprising an herbal extract produced by the process. The invention also provides a flavor system comprising an herbal extract comprising thymol, eugenol, carvacrol and eucalyptol. The invention further provides a flavor system comprising a thyme extract having a minimum inhibitory concentration of less than about 3%. Additionally, the invention provides an oral product comprising a flavor system.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application No. 61/034,455, filed Mar. 6, 2008, and U.S. Provisional Application No. 61/034,908 filed Mar. 7, 2008, and U.S. Provisional Application No. 61/034,902, filed Mar. 7, 2008 and U.S. Provisional Application No. 61/073,640, filed Jun. 18, 2008; all of which are incorporated by reference herein.
  • BACKGROUND
  • Over the years, many oral products have been developed to include additional ingredients that promote oral hygiene, such as tartar control agents or antibacterial agents, although each of these ingredients brings an added benefit they also cause negative aesthetics, particularly taste. There is still a need for products with improved aesthetics and taste. The present invention provides a method of producing an herbal extract and also a flavor system that can provide both antimicrobial benefits with pleasant organoleptic properties for use in oral products.
  • SUMMARY
  • In one aspect, the invention provides a method for preparing an herbal extract including (1) treating an herb with a low temperature liquid CO2 extraction in the presence of an alcohol to produce an alcohol-herb extract; (2) distilling the alcohol-herb extract to remove at least a portion of the alcohol and produce a first herbal extract; and (3) molecularly distilling the first herbal extract to produce a second herbal extract.
  • In one aspect, the invention provides a flavor system including an herbal extract produced by the above process.
  • In yet another aspect, the invention provides a flavor system including an herbal extract comprising thymol, eugenol, carvacrol and eucalyptol.
  • In a further aspect, the invention provides a flavor system comprising a thyme extract having a minimum inhibitory concentration for at least one of Porphyromonas gingivalis, Actinomycess viscosus, Actinomyces naeslundii, Streptococcus mutans, and Fusobacterium nucleatum, and the minimum inhibitory concentration is less than about 3%.
  • In another aspect, the invention provides an oral product comprising one of the flavor systems of the present invention.
  • BRIEF DESCRIPTION OF DRAWINGS
  • FIG. 1 is a schematic diagram of a system to extract an herbal extract, including treating an herb to a low temperature liquid CO2 extraction process in the presence of ethanol.
  • FIG. 2 is a schematic diagram of a liquid CO2-alcohol extraction process.
  • FIG. 3 is a schematic diagram of a process to remove alcohol from an alcohol-herbal extract resulting from a liquid CO2-alcohol extraction process, using low vacuum distillation.
  • FIG. 4 is a schematic diagram of a molecular distillation process to produce a final herbal extract that is a concentrated distillate.
  • FIG. 5 is a graph of percent release of Marker 1, thymol, and Marker 2, menthol, from chewing gum versus time, to monitor flavor release.
  • DETAILED DESCRIPTION
  • Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.
  • It also is understood that any numerical range recited herein includes all values from the lower value to the upper value. For example, if a concentration range is stated as 1% to 50%, it is intended that values such as 2% to 40%, 10% to 30%, or 1% to 3%, etc., are expressly enumerated in this specification. These are only examples of what is specifically intended, and all possible combinations of numerical values between and including the lowest value and the highest value enumerated are to be considered to be expressly stated in this application.
  • The invention provides a process of making an herbal extract. The herbal extract may be derived from thyme, oregano, cilantro, ginger, lavender, allspice, basil, bay, celery seed, pimento, lemongrass, parsley, onion, mustard, tarragon, sage, rosemary, coriander, marjoram, cumin, fennel, cinnamon, clove, black peppercorn and the like. One particularly suitable herbal extract comprises thyme. The herbal extract comprises a mixture of compounds, both active and inactive in providing antimicrobial efficacy and flavor. In a suitable embodiment, the invention provides a process that produces a thyme extract with unique flavoring, coloring, and antimicrobial properties. The process generally includes the following: 1) a first low temperature liquid CO2-alcohol extraction process; 2) a low vacuum distillation process; and 3) a molecular distillation process. The combination of these steps provides a highly concentrated, low color, high flavor and antimicrobial activity herbal extract.
  • The invention also provides a flavor system for the addition to compositions of oral products such as toothpaste, mouth rinse, gums, lozenges, and the like. The flavor system comprises an herbal extract. The flavor system may also include at least one characterizing flavor component, such as a flavor oil. The flavor system may include a second characterizing flavor component, such as menthol crystals. One suitable embodiment of the flavor system comprises thyme extract, peppermint oil and menthol crystals. The compositions are suitably non-toxic and have antimicrobial activity.
  • In another aspect, the invention provides a flavor system that provides antimicrobial activity, wherein the antimicrobial activity is measured by a minimum inhibitory concentration. The flavor system comprises an herbal extract, and has a minimum inhibitory concentration that is less than about 3%, less than about 2%, less than about 1%, less than about 0.5%, less than about 0.3%, less than about 0.2%, less than about 0.1%, less than about 0.05% for at least one of Porphyromonas gingivalis, Actinomyces viscosus, Actinomycess naeslundii, Streptococcus mutans, and Fusobacterium nucleatum.
  • In yet another aspect, the invention provides an oral composition having antimicrobial activity, the oral composition comprising a flavor system including an herbal extract and at least one characterizing flavor component.
  • In one aspect, the invention provides a method for producing an herbal extract. The method comprises 1) extracting an alcohol-herbal extract from the herb using a liquid CO2-alcohol extraction at temperatures less than about 25° C.; 2) distilling the alcohol-herbal extract under vacuum to remove at least a portion of the alcohol and produce a first herbal extract; and 3) molecularly distilling the first herbal extract to produce a second herbal extract.
  • The first step includes treating the herb to a low temperature liquid CO2 extraction process in the presence of ethanol. This process is illustrated in FIG. 1 and FIG. 2.
  • Dry herbs (1) are milled on a hammermill with an about 1 millimeter to about 7 millimeter screen to increase the surface area and rupture the herb. The herb is blended with at least about 10%, at least about 15%, at least about 20%, at least about 25%, or at least about 30% of its own weight of de-ionized water, using a ribbon mixer or similar equipment until homogenous, e.g., about 5 minutes. The dampened herb material (1) is packed into a series of extraction columns (20). The columns are treated by dynamic flow of liquid carbon dioxide (10) injected with alcohol (11) as a co-extraction entrainer. In a suitable embodiment, the amount of CO2-alcohol used can be measured as a mean flow rate through the extraction column. Suitable flow rates include at least about 150 kg/hr, at least about 175 kg/hr, at least about 200 kg/hr, at least about 222 kg/hr, or at least about 240 kg/hr. The flow rate may be less than about 350 kg/hr, less than about 325 kg/hr, less than about 300 kg/hr, less than about 275 kg/hr, or less than about 260 kg/hr.
  • The ratio of CO2 to alcohol may vary according to the herb being processed. In a suitable embodiment, the alcohol is provided in at least about 0.1%, at least about 0.2%, at least about 0.3%, at least about 0.5%, at least about 0.7%, at least about 1.0%, or at least about 2.0% by weight in the liquid CO2. In a suitable embodiment, the alcohol is provided at a mean flow rate of 1 kg/hr with the CO2 provided at a mean flow rate of 250 kg/hr. In one embodiment, the alcohol is ethanol.
  • The CO2-alcohol is provided to the extraction columns under pressure, the pressure being at least about 35 atmosphere, at least about 40 atmosphere, at least about 45 atmosphere, at least about 50 atmosphere, at least about 55 atmosphere, or at least about 60 atmosphere, wherein a suitable range is about 45-55 atmosphere. The process is driven by an approximately 10 atmosphere differential within the plant during operation.
  • In certain embodiments, this process is carried out at temperatures that are less than about 25° C., less than about 20° C., less than about 15° C., less than about 12° C. Suitably the temperature may be between about 0° C. and about 10° C. In a suitable embodiment, the temperature is about 7° C.±1° C. These temperatures are below the temperatures used in supercritical CO2 extraction which occur above the critical temperature 31° C., and more typically at 40-60° C., and very often higher. The lower temperatures concentrate more of the volatile components in the extract and avoid the decomposition of components. The liquid CO2 phase extraction is more selective for more volatile components and therefore achieves higher concentrations of them.
  • The liquefied carbon dioxide-alcohol is a unique solvent mixture that dissolves the low molecular weight organoleptically active components of the herb. The low temperature and pressurized system prevents the degradation and loss of volatiles which may typically occur with a traditional essential oil distillation process, while higher molecular weight unwanted materials such as heavier fats, waxes, pigments, sugars, starches and tannins are excluded by this extraction process. The CO2-alcohol-herb extract solution emerging from the extraction columns is passed to a heat exchanger (21) where the temperature is raised a few degrees within the closed system, and the CO2 is changed to vapor by the change in temperature and removed via pipe work to the compressor for recycling to liquid CO2 through the process. The alcohol-extract is collected from the system as a cold foam product, and as the foam warms to room temperature any residual CO2 vaporizes and leaves the alcohol-herbal extract (2). The time of extraction depends on the material used and can be readily determined by one of ordinary skill in the art. For a thyme extract, the extraction time per extraction column filled with thyme leaves (about at least 25 kg, more suitably 28 kg) is at least about 4 hours.
  • FIG. 2 charts a description of the CO2-alcohol extraction process in detail. Liquid CO 2 1 enters the system into a liquid CO2 holding tank 2. The CO2 is processed through a heat exchanger 3 and a refrigeration unit 4 to provide the liquid CO2 at the desired temperature of about 7° C. The liquid CO2 is injected with alcohol from an alcohol storage tank 6 via a co-entainer pump 7. The liquid CO2-alcohol solvent is pumped through a set of extraction columns 8A-E which hold the milled herbal leaves. The liquid CO2-alcohol -herbal extract is processed through the heat exchanger 3 (giving an initial input of energy into the extract) to an automatic mixing valve 9, an automatic flow control valve 10 and filters 11 into a main condenser-heat exchanger 12 where the CO2 is recycled back into the CO2 holding tank 2 and the product is collected via the product collection pump 17 to a product tap 18. CO2 is also purified to be reused and recovered from the condenser-heat exchanger 12 through a demisting filter 13, a compressor 14, a de-oil misting filter 15 and at a vapor temperature control 16. A vaporizer 19 pumps warm vapor back into the extraction columns 8.
  • A second step of the process includes processing the alcohol-herbal extract from the extraction through a low vacuum distillation process to remove the alcohol as depicted in FIG. 3 and form a first herbal extract (3). This process can be carried out using a suitable vacuum still (23). The alcohol is removed under low vacuum distillation at typically a temperature of at least about 20° C., at least about 30° C., at least about 35° C., at least about 40° C., at least about 45° C., at least about 50° C., at least about 55° C., or at least about 60° C., one suitable range is between about 30 to about 40° C., finishing at a maximum of about at least 60° C., to reduce the alcohol content to a residual level. Residual alcohol may be less than about 25%, less than about 20%, less than about 15%, or less than about 10%. The residual alcohol may be at least about 0.05%, at least about 0.1%, at least about 0.2%, at least about 0.5%, at least about 1%, at least about 2%, or at least about 5%.
  • A third step of the process includes a molecular distillation process. A falling-film short path still may be used. Suitable stills such as models KD5 or KD10 Molecular Stills are available from UIC GmbH of Germany. This step of the process is depicted in FIG. 4. This special design of the still subjects the material being processed to heating for the briefest possible time while allowing a very high vacuum to be achieved, lowering the vaporizing temperature and thus greatly limiting the overall exposure of the extract. Suitably, the liquid extract (3) is continuously feed into the still (40) and passes down the inside of a heated jacket (28), which is at about at least 80° C., at least about 90° C., or at least about 100° C., as a thin film produced by the centrifugal force of the rotating rollers (27), and falls by gravity to be collected. This process is carried out under high vacuum conditions, wherein the pressure is suitably at least about 5×10−4 mbar, at least about 1×10−3 mbar, at least about 1.5×10−3 mbar, or at least about 2×10−3 mbar. The pressure is suitably at least less than about 1×10−2 mbar, less than about 5×10−2 mbar, less than about 7×10−2 mbar, or less than about 1×10−3. The extract is subjected to heat typically for only a few minutes. Suitably, the extract passes through the system at a rate of about at least 1 kg/hr, at least about 2 kg/hr, at least about 3 kg/hr, at least about 5 kg/hr, at least about 7 kg/hr, at least about 8 kg/hr, or at least about 10 kg/hr. In a suitable embodiment, the rate is about 1 to about 2 kg/hr for a KD10 Molecular Still. The volatile material passes as a laminar flow of vapor across a very short path onto a condenser (30) which is concentric at the center of the roller assembly, and falls by gravity into a receiver. This laminar flow, coupled with the use of high efficiency rotary and oil diffusion vacuum pumps and a liquid nitrogen trap at −200° C. allows vacuum pressures down to 10−6 atmosphere to be achieved. Materials in the extract that would be damaged or even decomposed during traditional distillation are separated and purified into the final herbal extract. This process produces a second herbal extract (4) that is a concentrated distillate with reduced color.
  • As mentioned above, the invention also provides a flavor system comprising the herbal extract. The herbal extract is suitably provided as at least about 1% wt/wt, at least about 2% wt/wt, at least about 4% wt/wt, at least about 6% wt/wt, at least about 9% wt/wt, at least about 15% wt/wt, at least about 20% wt/wt, or at least about 25% wt/wt of the flavor system. The thyme extract is suitably provided as less than about 30% wt/wt, less than about 20% wt/wt, less than about 15% wt/wt, less than about 12% wt/wt of the flavor system.
  • One suitable herbal extract is a thyme extract derived from dry thyme by the process described above. The thyme extract is a mixture of compounds, both active and inactive in providing antimicrobial efficacy and flavor. Suitable processes produce thyme extract with unique flavoring and antimicrobial properties. This thyme extract has unique and beneficial properties from thyme oils produced by other known methods. The main active ingredients of the thyme extract that provide antimicrobial efficacy include thymol, eugenol, carvacrol and eucalyptol. Thyme extract also includes a number of inactive ingredients, some of which can be found in Table 7. The unique chemical composition of this extract provides the unique flavor, color and antimicrobial properties. The thyme extract provides a more appealing flavor in addition to antimicrobial benefits. One example of a suitable thyme extract is THYME TEMPLAR™ available from Sensient Flavors, Inc. (Indianapolis, Ind.).
  • The flavor system may also include at least one characterizing flavor component that provides organoleptic properties of pleasant taste and smell, and may provide additional antimicrobial activity as well. A first characterizing flavor component may constitute suitably at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 47%, at least about 50%, at least about 60%, or at least about 70% wt/wt of the flavor system. The first characterizing flavor component may constitute less than about 70% wt/wt, less than about 60% wt/wt, less than about 55% wt/wt, less than about 50% wt/wt, less than about 40% wt/wt, or less than about 20% wt/wt of the flavor system. The first characterizing flavor component may be a flavor oil. Examples of flavor oils that may be used include, but are not limited to, peppermint oil, spearmint oil, oil of wintergreen, lavender oil, rosemary oil, clove oil and cinnamon oil.
  • The flavor system may also include a second characterizing flavor component. The flavor system may suitably includes at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50% wt/wt, at least about 60% wt/wt, or at least about 70% wt/wt of the secondary flavor component. The flavor system may suitably include less than about 70%, less than about 60%, less than about 50%, less than about 40%, less than about 30%, less than about 20%, less than about 15%, or less than about 10% of the secondary flavor component. One example of a secondary flavor component includes, but is not limited to, menthol crystals, C10H20O, which are an organic compound made synthetically or obtained from mint oils, most commonly produced from Mentha arvensis. Menthol is a waxy, clear or white crystalline substance commercially available from Monarchy Aromatics, Ltd.
  • Additional examples of first and second characterizing flavor components may be from oils, crystals, liquid concentrates, synthetic flavors, or combinations thereof. Additional characterizing flavor components may include, but are not limited to, oils derived from plants and fruit such as citrus oils, fruit essences, peppermint oil, spearmint oil, other mint oils, clove oil, oil of wintergreen, cinnamon, anise, artificial flavoring agents such aldehyde flavors including, but are not limited to, acetaldehyde (apple), benzaldehyde (cherry, almond), anisic aldehyde (licorice, anise), cinnamic aldehyde (cinnamon), citral, i.e., alpha citral (lemon, lime), neral, i.e., beta citral (lemon, lime), decanal (orange, lemon), ethyl vanillin (vanilla, cream), heliotropine, i.e., piperonal (vanilla, cream), vanillin (vanilla, cream), alpha-amyl cinnamaldehyde (spicy fruity flavors), citronellal (modifies, many types), decanal (citrus fruits), aldehyde C-8 (citrus fruits), aldehyde C-9 (citrus fruits), aldehyde C-12 (citrus fruits), 2-ethyl butyraldehyde (berry fruits), hexenal, i.e., trans-2 (berry fruits), tolyl aldehyde (cherry, almond), veratraldehyde (vanilla), 2,6-dimethyl-5-heptenal, i.e., Melonal (melon), 2,6-dimethyloctanal (green fruit), and, 2-dodecenal (citrus, mandarin). Those skilled in the art will recognize that natural and artificial secondary flavor components may be combined in any sensorally acceptable fashion. All such flavors and flavor blends are contemplated by the present invention.
  • As mentioned above, the invention also provides a flavor system comprising an herbal extract. “Antimicrobial activity,” as described herein, is the ability of an herbal extract to retard the growth of and/or prevent the growth of oral bacteria. Examples of representative gram-positive and gram-negative oral bacteria include, but are not limited to, Actinmoyces viscosus Actinomyces naeslundii, Fusobacteriumm nucleatum, Porphyromonas gingivalis, Streptococcus mutans, and Streptococcus sanguis. Anti-microbial activity can be measured by the minimum inhibitory concentration of the agent. The minimum inhibitory concentration of an herbal extract is the concentration of the extract within a test sample at which no bacterial growth is observed. The test sample may be saliva or a suitable bacterial culture. In the examples below, the minimum inhibitory concentration is provided as a percentage.
  • The minimum inhibitory concentration for the herbal extract is measured as a percent volume (e.g., 1% would be one part flavor system in 99 parts test sample) as described in the example below. The herbal extract may provide antimicrobial activity as measured by minimum inhibitory concentration (MIC) of at least about 0.01%, at least about 0.05%, at least about 0.1%, at least about 0.2%, at least about 0.5% for an oral bacteria. The herbal extract may provide antimicrobial activity as measured by minimum inhibitory concentration of less than about 5%, less than about 3%, less than about 2%, less than about 1%, less than about 0.5%, less than about 0.3%, less than about 0.2%, less than about 0.1% for an oral bacterial.
  • The flavor system may include additional antimicrobial agents. Suitable antimicrobial agents include, but are not limited to, cedarwood oil, chloramphenicol, berberine, Glycyrrhiza glabra extract, juicy fruit basil oil, juniper berries oil, lemon basil oil, orally active metallic ion such as salts of zinc, tin, silver and copper, hexylresorcinol, cetylpyridinium chloride, chlorhexidine digluconate, 5-chloro-2-(2,4-dichlorophenoxy)-phenol, commonly referred to as triclosan, phthalic acid and its salts including, but not limited to those disclosed in U.S. Pat. No. 4,994,262, substituted monoperthalic acid and its salts and esters as disclosed in U.S. Pat. Nos. 4,990,329, 5,110,583, and 4,716,035, magnesium monoperoxy phthalate, chlorhexidine (Merck Index, no. 2090), alexidine (Merck Index, no. 222, hexetidine (Merck Index, no. 4624), sanguinarine (Merck Index, no. 8320), benzalkonium chloride (Merck Index, no. 1066), salicylanilide (Merck Index, no. 8299), domiphen bromide (Merck Index, no. 3411), cetylpyridinium chloride (CPC) (Merck Index no. 2024, tetradecylpyridinium chloride (TPC), N-tetradecyl-4-ethyllpyridinium chloride (TDEPC), octenidine, delmopinol, octapinol, and other piperidino derivatives, niacin preparations, zinc/stannous ion agents, antibiotics such as augmentin, amoxicillin, tetracycline, doxycycline, minocycline, and metronidazole; and analogs and salts of the above; essential oils including thymol, geraniol, carvacrol, citral, hinokitiol, eucalyptol, catechol (particularly 4-allyl catechol) and mixtures thereof; methyl salicylate; hydrogen peroxide; metal salts of chlorite and mixtures of all of the above. Each of the patents recited herein are hereby fully incorporated by reference.
  • Sweeteners may also be included in the flavor system. Suitable sugar sweeteners include, but are not limited to, sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, glucose, galactose, corn syrup solids, stevioside, Lo-Han Guo, and the like, alone or in combination. Sugarless sweeteners include, but are not limited to, sugar alcohols such as sorbitol, mannitol, xylitol, hydrogenated starch hydrolysates, maltitose, and the like, alone or in combination. High intensity artificial sweeteners can also be used alone or in combination with other sweeteners. These sweeteners include, but are not limited to, sucralose, aspartame, MAPM derivatives such as neotame, salts of acesulfame, altitame, saccharin and its salts, cyclamic acid and its salts, glycyrrhizinate, dihydrochalcones, thaumatin, monellin, and the like, alone or in combination.
  • In one embodiment, the flavor systems are manufactured by mixing a first characterizing flavor component (e.g., peppermint oil) with a second characterizing flavor component (e.g., menthol crystals) and heating the mixture to at least about 35° C., to at least about 40° C., to at least about 45° C., to at least about 50° C., to at least about 55° C., to at least about 60° C., to at least about 65° C. until the second characterizing flavor component is melted in a standard mixer. The mixture is mixed until homogenous and then cooled. The thyme extract is added to the mixture and mixed until homogenous. In another embodiment, the thyme extract may be added to a first characterizing flavor component without the use of a second flavoring component and mixed until homogenous. The thyme extract and first characterizing flavor component may be mixed at room temperature. Other flavors may also be added and mixed until homogenous.
  • The flavor systems may be used in the preparation of spray dried flavor compositions. The flavor systems may be combined with encapsulating agents such as the starch-based encapsulating agent Hi-Cap 100 from National Starch (Bridgewater, N.J., U.S.A.) and water. Other suitable encapsulating agents may include N-Lok® 1930, CAPSUL®, CAPSUL®TA (all from National Starch), and EmCap™ (from Cargill, Inc., Cedar Rapids, Iowa, U.S.A.). The water and starch-based encapsulating agent may be mixed, and a flavor system may be added to the starch and water mixture to form an emulsion. The emulsion may be dried with an inlet temperature of about 160° C. The encapsulating agent may be present in amounts of at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, or at least about 50% by weight of the total spray dried flavor composition. The encapsulating agent may be present in a suitable amount less than about 50%, less than about 40%, less than about 20%, less than about 10%, or less than about 5% by weight of spray dried flavor composition. The flavor system may be added to amounts of at least about 0.5%, at least about 0.8%, at least about 1%, at least about 2%, at least about 4%, at least about 6%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, or at least about 70% by weight of the total spray dried flavor composition. The flavor system may be used in the composition in a suitable amount less than about 60%, less than about 50%, less than about 20%, less than about 12%, less than about 10%, less than about 7%, less than about 5%, less than about 3%, or less than about 2% by weight of spray dried flavor composition. The spray dried flavor formulations may be used with or without other flavor systems and may be incorporated into compositions such as water, chewing gums, toothpaste, mouth rinse, liquid dentifrice, lozenges, liquid spray, and edible films.
  • The flavor systems may be used in the preparation of oral compositions for oral products by the addition of the flavor system at amounts of at least about 0.5%, at least about 0.8%, at least about 1%, at least about 2%, at least about 4%, at least about 6%, at least about 10% by weight of the total oral composition. The flavor system may be used in the oral composition in a suitable amount less than about 20%, less than about 12%, less than about 10%, less than about 7%, less than about 5%, less than about 3%, less than about 2% by weight of the oral composition. Oral compositions may be products which in the ordinary course of usage are not intentionally swallowed for purposes of systemic administration of particular therapeutics agents, but are rather retained in the oral cavity for a time sufficient to contact substantially all the dental surfaces and/or oral tissues for purposes of oral activity. Methods of preparing the oral compositions may include mixing the flavor system by conventional methods to an oral delivery agent. Oral delivery agents include, but are not limited to, a toothpaste, mouth rinse, liquid dentifrice, gum, lozenges, liquid spray, and edible films. Toothpaste may be paste or gel formulations unless otherwise specified. The amount of flavor system added depends on the particular oral composition to which it is added. For example, chewing gums may include at least about 0.5%, more suitably at least about 2% wt/wt of flavor system while edible oral films may comprise at least about 6%, more suitable at least about 10% wt/wt of the flavor system due to their very low weight. The oral compositions comprise a sufficient amount of the flavor system to provide antimicrobial activity.
  • The oral compositions may include sweeteners as described above. Further, the oral compositions may include other antimicrobial agents. The oral compositions may also contain other flavoring agents, if desired. The flavoring agents may include essential oils, synthetic flavors or mixtures thereof including, but not limited to, oils derived from plants and fruits, such as citrus oils, fruit essences, peppermint oil, spearmint oil, other mint oils, clove oil, oil of wintergreen, anise and the like. Artificial flavoring agents and components may also be used. Natural and artificial flavoring agents may be combined in any sensorially acceptable fashion. Flavoring may include a cooling agent to enhance the flavor and perceived freshness.
  • The oral compositions may be chewing gums or any variation including but not limited to bubble gums, pellets, gum balls or sticks. Chewing gums may be coated or not coated and be of a variety of flavors, shapes and sizes. A chewing gum composition includes a gum base, and a suitable amount of the flavor system as described above. Chewing gum may be manufactured by any suitable conventional method. The base for the chewing gum includes an elastomer of a type normally employed in chewing gums, e.g., chicle, gum, jelutong, balata, crown gum, gutta-percha, sorva, butadiene-styrene copolymer, polyisobutylene, isobutylene-isoprene copolymer, polyethylene, and the like or mixtures thereof. Softeners may be added to chewing gum in order to optimize the chewability and mouth-feel of the gum. Chewing gums may include at least about 0.1%, at least about 0.5%, at least about 1%, at least about 2% of the flavor system. Chewing gums may include less than about 3%, less than about 2.5%, less than about 2% of the flavor system.
  • The following examples further describe and demonstrate embodiments within the scope of the present invention. These examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention as many variations thereof are possible without departing from the spirit and scope.
  • EXAMPLES
  • All percentages described in the following examples are percent weight unless indicated otherwise.
  • Example 1
  • Dry thyme leaves were milled on a hammermill with a 3 millimeter screen to increase the surface area and rupture the leaves. 28 kg of dry milled thyme leaves were added to 8.4 kg of water and mixed in a ribbon mixer until homogenous, about 5 minutes. The moistened thyme leaves were added to a stainless steel extraction column. Each extraction column was loaded with 28 kg dry thyme leaves. Three extraction columns were used. Liquid CO2 was injected with 1 kg/hr of ethanol (96A % natural fermentation grade), the CO2 provided to the extractor at a rate of 250 kg/hr for 4 hours per extraction column under 45 atmosphere pressure at 7° C.±1°. The CO2-ethanol-thyme extract was collected and passed through a heat exchanger which vaporizes the CO2 to produce an ethanol-thyme extract to yield about 17% the weight of the initial leaves at this stage. The ethanol-thyme extract was processed by low vacuum distillation at 35° C. at 200 mbar to remove the ethanol in a batch still. The distilled thyme-extract was then treated on a thin-film molecular distillation unit (KD5 model, UIC GmbH of Germany) under vacuum pressure of 10−6 atmospheres at 100° C. at a flow rate of 1 kg per hour. The thyme extract was analyzed by mass spectroscopy and an exemplary list of the chemical composition of the thyme extract is shown in Table 1.
  • TABLE 1
    Thyme extract
    Compound %
    Ethanol 5.03
    Acetic Acid 0.349
    1-octen-3-ol 1.031
    p-cymene 6.382
    Eucalyptol 0.43
    Linalool 2.354
    Camphor 0.232
    Boreol 1.423
    4-terpineol 0.542
    thymol methyl ether 0.701
    carvacrol methyl ether 1.141
    Thymol 58.468
    Carvacrol 4.436
    Eugenol 0.589
    beta-caryophyllene 1.326
    caryophyllene oxide 0.794
    Total 85.228
  • Example 2
  • A flavor system was formulated using the components set forth in Table 2.
  • TABLE 2
    % material
    % material in final
    Flavor B in formula flavor system
    Thyme extract (THYME TEMPLAR ™,   1-50% 1-12%
    Sensient Flavors, Indianapolis, IN) 0.01-5%
    Primarily composed of: 0.1-10%
    Thymol
    Eugenol
    Carvacrol
    Eucalyptol
    Menthol crystals 15-50%
    (Monarchy Aromatics, Ltd,)
    Peppermint oil 25-60%
    (F. D. Copeland and Sons, Ltd)
    Natural Thymol 0.1-0.8%
    TOTAL 100%
  • The peppermint oil and menthol crystals were added together in a standard mixer and heated to 113° F. and mixed until homogenous. The mixture was then cooled and the thyme extract and natural thymol were added and mixed until homogenous.
  • Example 3
  • A flavor system formulation was prepared using the following formulation in Table 3.
  • TABLE 3
    % material
    % material in final
    Flavor C in formula flavor system
    Thyme extract (THYME TEMPLAR ™, 50%  5%
    Sensient Flavors, Indianapolis, IN)  7% (2.5-3%)
    Primarily composed of:
    Thymol
    Eugenol
    Carvacrol
    Eucalyptol
    Menthol crystals
    40%
    (Monarchy Aromatics, Ltd,)
    Peppermint oil 55%
    (F. D. Copeland and Sons, Ltd)
    TOTAL 100% 
  • The peppermint oil and menthol crystals were added together in a standard mixer, heated to 113° F. until the menthol crystals dissolved, and the mixture was cooled. The thyme extract was then added to the mixture and mixed until homogeneous.
  • A batch of flavor system formulation C was analyzed by gas chromatography/mass spectrometry (GC/MS) using standard methods providing the main chemical composition of formulation C as shown in Table 4.
  • TABLE 4
    Flavor C composition
    Compound %
    b-cymene 0.376
    Eucalypto + Limonene 2.892
    Menthone 13.125
    Isomenthone 2.798
    Menthofuran 1.609
    Neomenthol 2.317
    Menthol 63.53
    Pulegone 1.059
    Thymol 2.506
    Methyl Acetate 2.578
    Beta-caryophyllene 1.038
    Germacrene 0.416
    Other ingredients 5.8
    Total 100
  • Example 4
  • A flavor system formulation was prepared as described in Example 3 but using the following formulation in Table 5.
  • TABLE 5
    % material
    % material in final
    Flavor D in formula flavor system
    Thyme Templar (THYME TEMPLAR ™, 50%  9%
    Sensient Flavors, Indianapolis, IN)  7% (2.5-3%)
    Primarily composed of:
    Thymol
    Eugenol
    Carvacrol
    Eucalyptol
    Menthol crystals 38%
    (Monarchy Aromatics, Ltd,)
    Peppermint oil 53%
    (F. D. Copeland and Sons, Ltd)
    TOTAL 100% 
  • A batch of flavor system of formulation D was analyzed as described in Example 3. The formulation of the main chemical compositions of formula D can be found in Table 6.
  • TABLE 6
    Flavor D composition
    Compound %
    b-cymene 0.638
    eucalypto + Limonene 2.623
    Menthone 11.805
    Isomenthone 2.53
    Menthofuran 1.445
    Neomenthol 2.122
    Menthol 62.895
    Pulegone 1
    Thymol 4.963
    Methyl Acetate 2.514
    Beta-caryophyllene 0.97
    Germacrene 0.379
    Other 6.116
    Total 100
  • Example 5 Chewing Gum Containing Flavor Systems
  • Chewing gum compositions are prepared by incorporating the flavor systems of Examples 3 and 4 with a chewing gum (Trident gum manufactured by Cadbury Adams located in Parsippany N.J.). The flavor systems are added at 2% weight of the composition of the gum.
  • Example 6 Liquid Filled Chewing Gum
  • Liquid filled chewing gum compositions, Dentyne Ice (manufactured Cadbury Adams located in Parsippany N.J.), are prepared by incorporating the flavor systems of Examples 3 and 4, the liquid portion of Dentyne Ice gum filling is mixed with 0.1% of the flavor system and the solid portion of the Dentyne Ice gum base is mixed with 3% of the flavor system.
  • Example 7 Liquid Filled Chewing Gum
  • Liquid filled chewing gum compositions, Dentyne Ice (manufactured by Cadbury Adams located in Parsippany N.J.), are prepared by incorporating the flavor systems of Examples 3 and 4, the liquid portion of Dentyne Ice gum filling is mixed with 1.0% of the flavor system and the solid portion of the Dentyne Ice gum base is mixed with 3% of the flavor system.
  • Example 8 Mouth Rinse Containing Flavor System
  • Mouth rinse compositions are prepared by mixing 2% by weight of the flavor systems of Examples 3 and 4 with a mouth rinse.
  • Example 9 Toothpaste Containing Flavor System
  • Toothpaste compositions are prepared by mixing 2% of flavor systems of Examples 3 and 4 with unflavored toothpaste until the mixture is homogenous.
  • Example 10 Edible Film Containing Flavor System
  • Edible film compositions are prepared by mixing 10% by weight of the flavor systems of Examples 3 and 4 with a substance to form an edible film.
  • Example 11 Composition of Thyme Extract
  • The composition of the thyme extract (THYME TEMPLAR™) obtained by ethanol CO2 extraction process was analyzed as described in Example 3. An exemplary list of the chemical composition is shown in Table 7.
  • TABLE 7
    Thyme extract
    Compound %
    Ethanol 5.03
    Acetic Acid 0.349
    1-octen-3-ol 1.031
    p-cymene 6.382
    Eucalyptol 0.43
    Linalool 2.354
    Camphor 0.232
    Boreol 1.423
    4-terpineol 0.542
    thymol methyl ether 0.701
    carvacrol methyl ether 1.141
    Thymol 58.468
    Carvacrol 4.436
    Eugenol 0.589
    beta-caryophyllene 1.326
    caryophyllene oxide 0.794
    Total 85.228
  • Example 12 Antimicrobial Activity of Flavor System
  • In vitro studies were preformed at Indiana University School of Dentistry at the Indiana University-Purdue University of Indianapolis (IUPUI) to test for the antimicrobial activity of the flavor systems. Porphyromonas gingivalis (PG, ATCC 33277), Actinomyces viscosus (AV, ATCC 19246), Actinomycess naeslundii (AN, ATCC 12104), Streptococcus mutans (SM, ATCC 25175), and Fusobacterium nucleatum (FN, ATCC 31647) were used to determine the minimum inhibitory concentration of 4 different flavor systems, A-D. Thyme extract is Flavor A as described in Example 8, and flavor systems B-D are as described in Examples 2-4. The four flavor systems were provided in an undiluted form and each flavor system was diluted to the working test solutions of 1.0%, 0.5%, 0.05%, and 0.001% (v/v) flavor system. Each testing system had a final volume of 2.0 ml, each containing at least 1×106 bacteria, adequate amount of the flavor system to obtain the working test solution, 1 ml of double strength enriched trypticase-soy broth and saline solution to bring the final volume up to 2 ml. Each test was run in triplicate.
  • Each testing sample was vigorously vortexed for 30 to 60 seconds to enhance physical contact of the bacteria with the relatively insoluble test products. A 1.0 ml aliquot was taken and placed into a flask containing 250 ml of Trypticase Soy Broth (TSB) supplemented with 0.25% (w/v) glucose. Flasks containing Porphyromonas gingivalis or Fusobacterium nucleatum were incubated at 37° C. in an anaerobic chamber (85% N2—10% CO2—5% H2), while the other bacteria flasks were incubated at 37° C. in ambient air. Samples were evaluated after 24 hours. The minimal inhibitory concentration (MIC) was determined as the test sample with the greatest dilution that exhibited no bacteria growth (e.g., remained clear, not turbid). MIC scores for each of the flavor systems for each of the bacteria tested are shown in Table 8.
  • TABLE 8
    Flavor FN AN AV PG SM
    A 0.05% 0.05%  0.05%  <0.01%   0.05% 
    B 0.05% 0.1% 0.5% 0.05% 0.5%
    C 0.05% 0.5% 0.1% 0.05% 0.1%
    D  0.1% 0.1% 0.5% 0.05%   1%
  • Example 13 Flavor Release from Chewing Gum
  • To test if adequate flavor is released from chewing gum, the chewing gums made in Example 5 were tested using a mechanical instrument to simulate human mastication of chewing gum, which can be found in Kleber et al. A mastication device designed for the evaluation of chewing gum is set forth in Journal of Dental Research, 1981, 109-114, which is incorporated herein in its entirety. Artificial saliva (15 ml) was placed in the reservoir, and the thermostatically controlled heating element was turned on to maintain the saliva and gum at body temperature for proper chewing consistency. One stick of test chewing gum (approximately 3 grams with 2% flavor system added) was placed in the warmed chamber and the artificial saliva was exposed to the chewing gum for 1 minute under chewing simulation conditions. All the artificial saliva (15 ml) was removed as quickly as possible with a pipette, delivered immediately into a glass bottle and sealed. The saliva was replaced with a fresh 15 ml aliquot, the chewing conditions restarted and the gum samples were treated for another minute. This process was repeated at the appropriate intervals to yield cumulative treatment times of 1, 2, 5, 10, 15, 20 and 30 minutes. The reservoir and mastication devices were thoroughly cleaned and rinsed, and the process repeated with another sample of chewing gum.
  • Two markers, Marker 1, thymol, and Marker 2, menthol, were selected to monitor flavor release based on quantity and antimicrobial efficiency. FIG. 5 shows release of the two markers at different predetermined times. Based on marker release, it was estimated that most of the flavor was released for Marker 2 between 5 and 10 minutes of chewing. Marker 1 was released constantly for the first 10 minutes and afterward decreases. Marker 2 was released at 55% in flavor C and flavor D while 40.8% and 33% of Marker 1 was released from flavor C and D respectively. It was estimated that enough flavor was released during the first 15-20 minutes to have antimicrobial activity based on the quantity released and the MIC results.
  • Example 14
  • Dry thyme leaves were milled on a hammermill with a 3 millimeter screen to increase the surface area and rupture the leaves. 28 kg of dry milled thyme leaves were added to 8.4 kg of water and mixed in a ribbon mixer until homogenous, about 5 minutes. The moistened thyme leaves were added to a stainless steel extraction column. Each extraction column was loaded with 28 kg dry thyme leaves. Three extraction columns were used. Liquid CO2 was injected with 1 kg/hr of ethanol (96A % natural fermentation grade), the CO2 provided to the extractor at a rate of 250 kg/hr for 4 hours per extraction column under 45 atmosphere pressure at 7° C.±1°. The CO2-ethanol-thyme extract was collected and passed through a heat exchanger which vaporizes the CO2 to produce an ethanol-thyme extract to yield about 17% the weight of the initial leaves at this stage. The ethanol-thyme extract was processed by low vacuum distillation at 35° C. at 200 mbar to remove the ethanol in a batch still. The distilled thyme-extract was then treated on a thin-film molecular still (KD5 model, UIC GmbH of Germany) under vacuum pressure of 10−6 atmospheres at 100° C. at a flow rate of 1 kg per hour.
  • Example 15
  • An anti-microbial spray dried flavor formulation was prepared by mixing water and a starch-based encapsulating agent such as Hi-Cap 100 (National Starch, Bridgewater, N.J., U.S.A.). An oil flavor system was prepared as described in Example 3 except with the formulation according to Table 9. The oil flavor system was added to the starch and water to form an emulsion at a concentration of 16% (wt/wt) flavor system, 24% (wt/wt) Hi-Cap 100, and 60% (wt/wt) water with an average particle size of about 0.5 μm. The emulsion was then spray dried with an inlet temperature of about 160° C.
  • TABLE 9
    % material
    % material in final
    Flavor E in formula flavor system
    Thyme Templar (THYME TEMPLAR ™, 50%
    Sensient Flavor, Indianapolis, IN)
    Menthol crystals  0%
    (Monarchy Aromatics, Ltd,)
    Peppermint oil 50%
    (F. D. Copeland and Sons, Ltd)
    TOTAL 100% 
  • The final spray dried formulation was made into a volatile oil composition and analyzed with GC-MS. The chemical composition is shown in Table 10. Encapsulation of the flavor system removed water and some (about 20-60%) of the volatile oils from the formulation, resulting in about 40% load encapsulation.
  • TABLE 10
    Anti-M Spray Dried
    Anti-microbial Compound %
    Carvacrol
       1%
    Thymol 12.098%
    Eugenol  0.25%
    Eucalyptol
       2%
    Menthol (from peppermint oil)  8.75%
    Other compounds 75.902%
    Total   100%
  • The anti-microbial spray dried flavor formulation may be incorporated into compositions such as water, chewing gums, toothpaste, mouth rinse, liquid dentifrice, lozenges, liquid spray, and edible films.
  • Example 16
  • A breath freshening spray dried flavor formulation was prepared by mixing water and a starch-based encapsulating agent such as Hi-Cap 100 (National Starch, Bridgewater, N.J., U.S.A.). The oil flavor system as prepared and described in Example 3 (5% THYME TEMPLAR™, 40% menthol crystals, 55% peppermint oil) was added to the starch and water mixture to form an emulsion at a concentration of 16% (wt/wt) flavor system, 24% (wt/wt) Hi-Cap 100, and 60% (wt/wt) water with an average particle size of about 0.5 μm. The emulsion was then spray dried with an inlet temperature of about 160° C.
  • The final spray dried formulation was made into a volatile oil composition and analyzed with GC-MS. The chemical composition is shown in Table 11. Encapsulation of the flavor system removed water and some (about 20-60%) of the volatile oils from the formulation, resulting in about 40% load encapsulation.
  • TABLE 11
    Breath Freshening Spray Dried
    Anti-microbial Compound %
    Menthol 22.891%
    Thymol  1.17%
    Eucalyptol   0.5%
    Carvacrol   0.5%
    Other compounds 74.939%
    Total   100%
  • The breath freshening spray dried formulation may be incorporated into compositions such as water, chewing gums, toothpaste, mouth rinse, liquid dentifrice, lozenges, liquid spray, and edible films.

Claims (33)

1. A method for preparing an herbal extract comprising:
a) treating an herb with a low temperature liquid CO2 extraction in the presence of an alcohol to produce an alcohol-herbal extract;
b) distilling the alcohol-herbal extract under vacuum to remove at least a portion of the alcohol and produce a first herbal extract; and
c) molecularly distilling the first herbal extract to produce a second herbal extract.
2. The method of claim 1, wherein the alcohol comprises ethanol.
3. The method of claim 1, wherein the herb is selected from the group consisting of thyme, oregano, clove, cilantro, cinnamon, ginger, lavender, allspice, basil, bay celery seed, pimento, lemongrass, parsley, onion, mustard, tarragon, sage, rosemary, coriander, marjoram, cumin, fennel, and black peppercorn.
4. The method of claim 1, wherein the low temperature is a temperature of less than about 25° C.
5. The method of claim 1, wherein the low temperature is a temperature of about 0° C. to about 10° C.
6. The method of claim 1, wherein the extract has a minimum inhibitory concentration for at least one of Porphyromonas gingivalis, Actinomycess viscosus, Actinomyces naeslundii, Streptococcus mutans, and Fusobacterium nucleatum, and the minimum inhibitory concentration is less than about 2%.
7. The method of claim 6, wherein the extract has a minimum inhibitory concentration of less than about 1%.
8. The method of claim 6, wherein the extract has a minimum inhibitory concentration of less than about 0.5%.
9. The method of claim 1, wherein step (b) is performed at a temperature of about 30° C. and about 50° C.
10. A flavor system comprising an herbal extract produced according to claim 1.
11. A flavor system comprising an herbal extract comprising thymol, eugenol, carvacrol and eucalyptol.
12. The flavor system of claim 11, wherein the herbal extract comprises about 1 to about 60 wt % thymol.
13. The flavor system of claim 11, wherein the herbal extract comprises about 0.01 to about 5 wt % eugenol.
14. The flavor system of claim 11, wherein the herbal extract comprises about 0.1 to about 10 wt % carvacrol.
15. The flavor system of claim 11, wherein the flavor system comprises about 1 to about 12 wt % herbal extract.
16. The flavor system of claim 11, wherein the flavor system comprises about 1 to about 12 wt % herbal extract, and the herbal extract comprises about 1 to about 60 wt % thymol, about 0.01 to about 5 wt % eugenol, and about 0.1 to about 10 wt % carvacrol.
17. The flavor system of claim 11, further comprising at least one characterizing flavor component.
18. The flavor system of claim 17, wherein the at least one characterizing flavor component is selected from the group consisting of flavor oils, menthol crystals, citrus oils, fruit essences, cinnamon, anise, and artificial flavoring agents.
19. The flavor system of claim 17, wherein the at least one characterizing flavor component is a flavor oil, and the flavor oil is selected from the group consisting of peppermint oil, spearmint oil, oil of wintergreen, lavender oil, rosemary oil, clove oil, cinnamon oil and combinations thereof.
20. The flavor system of claim 11, further comprising at least one additional antimicrobial agent.
21. The flavor system of claim 11, wherein the system has a minimum inhibitory concentration for at least one of Porphyromonas gingivalis, Actinomycess viscosus, Actinomyces naeslundii, Streptococcus mutans, and Fusobacterium nucleatum, and the minimum inhibitory concentration is less than about 3%.
22. The flavor system of claim 21, wherein the minimum inhibitory concentration is less than about 2%.
23. The flavor system of claim 21, wherein the minimum inhibitory concentration is less than about 1%.
24. A flavor system comprising a thyme extract having a minimum inhibitory concentration for at least one of Porphyromonas gingivalis, Actinomycess viscosus, Actinomyces naeslundii, Streptococcus mutans, and Fusobacterium nucleatum, and the minimum inhibitory concentration is less than about 3%.
25. The flavor system of claim 24, wherein the minimum inhibitory concentration is less than about 2%.
26. The flavor system of claim 24, wherein the minimum inhibitory concentration is less than about 1%.
27. The flavor system of claim 24, wherein the minimum inhibitory concentration is less than about 0.1%.
28. An oral product comprising the flavor system of claim 10.
29. The oral product of claim 29, wherein the oral product is toothpaste, gum, or lozenges.
30. An oral product comprising the flavor system of claim 11.
31. The oral product of claim 30, wherein the oral product is toothpaste, gum, or lozenges.
32. An oral product comprising the flavor system of claim 24.
33. The oral product of claim 32, wherein the oral product is toothpaste, gum, or lozenges.
US12/399,295 2008-03-06 2009-03-06 Herbal extracts and flavor systems for oral products and methods of making the same Abandoned US20090226549A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/399,295 US20090226549A1 (en) 2008-03-06 2009-03-06 Herbal extracts and flavor systems for oral products and methods of making the same
US13/490,206 US11211249B2 (en) 2008-03-06 2012-06-06 Herbal extracts and flavor systems for oral products and methods of making the same

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3445508P 2008-03-06 2008-03-06
US3490208P 2008-03-07 2008-03-07
US3490808P 2008-03-07 2008-03-07
US7364008P 2008-06-18 2008-06-18
US12/399,295 US20090226549A1 (en) 2008-03-06 2009-03-06 Herbal extracts and flavor systems for oral products and methods of making the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/490,206 Continuation US11211249B2 (en) 2008-03-06 2012-06-06 Herbal extracts and flavor systems for oral products and methods of making the same

Publications (1)

Publication Number Publication Date
US20090226549A1 true US20090226549A1 (en) 2009-09-10

Family

ID=40790678

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/399,295 Abandoned US20090226549A1 (en) 2008-03-06 2009-03-06 Herbal extracts and flavor systems for oral products and methods of making the same
US13/490,206 Active 2029-06-24 US11211249B2 (en) 2008-03-06 2012-06-06 Herbal extracts and flavor systems for oral products and methods of making the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/490,206 Active 2029-06-24 US11211249B2 (en) 2008-03-06 2012-06-06 Herbal extracts and flavor systems for oral products and methods of making the same

Country Status (2)

Country Link
US (2) US20090226549A1 (en)
WO (1) WO2009111685A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011029077A2 (en) 2009-09-04 2011-03-10 Sensient Flavors Llc Botanical extracts and flavor systems and methods of making and using the same
EP2544560B1 (en) 2010-03-09 2017-12-20 British American Tobacco (Investments) Limited Methods for extracting and isolating constituents of cellulosic material
US11211249B2 (en) 2008-03-06 2021-12-28 Sensient Flavors Llc Herbal extracts and flavor systems for oral products and methods of making the same
US11801209B2 (en) * 2017-12-21 2023-10-31 Firmenich Sa Cooling and flavor boosting compositions
WO2024028179A1 (en) * 2022-08-04 2024-02-08 Juan Antonio Santisteban Ortiz Biocidal composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102133753B1 (en) * 2018-11-09 2020-07-16 대한민국(농촌진흥청장) Oral composition containing silk protein, 4-hexylresorcinol and natural oil

Citations (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746553A (en) * 1971-03-24 1973-07-17 Kraft Sesame Corp Process for cleaning spices and herbs
US3821417A (en) * 1970-11-09 1974-06-28 Warner Lambert Co Flavor preservation in chewing gum compositions and candy products
US3947570A (en) * 1972-11-06 1976-03-30 Colgate-Palmolive Company Oral product
US4136065A (en) * 1973-08-06 1979-01-23 Asahi Kasei Kogyo Kabushiki Kaisha Extraction method for odor and flavor producing ingredients of foods and flowers and products produced
US4157401A (en) * 1978-04-24 1979-06-05 Life Savers, Inc. Chewing gum having improved flavor duration and shelf-life
US4158708A (en) * 1976-03-09 1979-06-19 Societe D'assistance Technique Pour Produits Nestle S.A. Spice extract
US4198432A (en) * 1971-06-03 1980-04-15 Studiengesellschaft Kohle Mbh Process for the production of spice extracts
US4208431A (en) * 1978-05-05 1980-06-17 Life Savers, Inc. Long-lasting chewing gum having good processibility and method
US4250196A (en) * 1979-10-09 1981-02-10 Life Savers, Inc. Center-filled chewing gums
US4316915A (en) * 1979-10-01 1982-02-23 Life Savers, Inc. Center-filled chewing gums
US4318906A (en) * 1979-06-25 1982-03-09 Establissement Rinrone Medicinal composition for external use for treating wounds
US4380506A (en) * 1980-04-08 1983-04-19 Lion Corporation Process for producing preservatives
US4431680A (en) * 1980-08-29 1984-02-14 International Flavors & Fragrances Inc. Process for augmenting or enhancing the aroma or taste of a peppermint oil based oral hygiene flavor by adding thereto methyl substituted oxobicyclo-4,4,0-decane derivatives
US4735358A (en) * 1986-03-04 1988-04-05 Daiken Iko Kabushiki Kaisha Method and apparatus of vaporizing active substances
US4803082A (en) * 1987-10-28 1989-02-07 Warner-Lambert Company Flavor and sweetness enhancement delivery systems and method of preparation
US4919149A (en) * 1988-07-08 1990-04-24 Stang Michael Andrew Contraception and flavor delivery system
US4923865A (en) * 1988-04-28 1990-05-08 U C B Societe Anonyme Substituted 1-(1H-imidazol-4-yl)alkyl-benzamides as anti-ischemics and as alpha-2-adrenergic receptor agonists
US4923685A (en) * 1987-07-30 1990-05-08 Henkel Kommanditgesellschaft Auf Aktien Antimicrobial flavored compositions having particular utility as mouth washes
US4925688A (en) * 1986-03-21 1990-05-15 Daniel Voituriez Method of diffusing essential oils and oleo-resins of spices in a carrier solution
US4935104A (en) * 1987-10-19 1990-06-19 Biolandes Process for the continuous hydro-distillation of plants
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol
US4985265A (en) * 1988-06-17 1991-01-15 L'air Liquide, Society Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Process for extraction of spices
US4990329A (en) * 1985-05-24 1991-02-05 The Procter & Gamble Company Composition for treating oral diseases
US4994262A (en) * 1988-10-14 1991-02-19 The Procter & Gamble Company Oral compositions
US5015464A (en) * 1987-03-25 1991-05-14 Amway Corporation Antiplaque chewing gum
US5017397A (en) * 1990-04-25 1991-05-21 Uy Nguyen Process for extracting antioxidants from Labiatae herbs
US5023020A (en) * 1987-06-10 1991-06-11 Shimizu Construction Co., Ltd. Method for supplying aromas, apparatus therefore and facilities provided with same
US5030459A (en) * 1989-11-07 1991-07-09 Warner-Lambert Company High impact mint flavor for high base chewing gum
US5032387A (en) * 1986-11-06 1991-07-16 Princeton Pharmaceutical Inc. Dental and oral hygiene preparations
US5091117A (en) * 1990-04-16 1992-02-25 Nabisco Brands, Inc. Process for the removal of sterol compounds and saturated fatty acids
US5093145A (en) * 1989-07-04 1992-03-03 Daregal Process for treating an aromatic plant or herb, or a plant containing essential oils
US5094843A (en) * 1990-09-10 1992-03-10 Beecham Inc. Antimicrobial toothpaste
US5110583A (en) * 1985-05-24 1992-05-05 The Procter & Gamble Company Peroxy acids composition for oral treatment
US5110608A (en) * 1988-12-29 1992-05-05 Warner-Lambert Company Chewing gums having longer lasting sweetness
US5120558A (en) * 1991-05-01 1992-06-09 Norac Technologies Inc. Process for the supercritical extraction and fractionation of spices
US5227183A (en) * 1990-12-24 1993-07-13 Mccormick & Company, Inc. Process for preparing dehydrated aromatic plant products and the resulting products
US5277910A (en) * 1991-12-12 1994-01-11 Mate Hidvegi Process for the preparation of a pharmaceutical composition selectively lowering the blood-lipid level
US5298238A (en) * 1991-11-07 1994-03-29 Warner-Lambert Company Liquid oral compositions comprising deterpenated and fractionated flavor oils
US5403587A (en) * 1993-04-22 1995-04-04 Eastman Kodak Company Disinfectant and sanitizing compositions based on essential oils
US5433949A (en) * 1992-03-11 1995-07-18 Skw Trostberg Aktiengesellschaft Process for the production of natural antioxidants
US5487902A (en) * 1989-07-24 1996-01-30 Fertin Laboratories Ltd. (Dansk Tyggegummi Fabrik A/S) Chewing gum composition with accelerated, controlled release of active agents
US5512285A (en) * 1993-02-22 1996-04-30 Advanced Phytonics Limited Fragrance extraction
US5525260A (en) * 1991-03-30 1996-06-11 Nestec S.A Preparation of spice extract antioxidant in oil
US5527552A (en) * 1993-04-01 1996-06-18 Kalamazoo Holdings, Inc. Lipid-soluble green tea catechin antioxidant solutions
US5633027A (en) * 1994-08-05 1997-05-27 Fuisz Technologies Ltd. Confectioneries containing stabilized highly odorous flavor component delivery systems
US5723106A (en) * 1993-01-27 1998-03-03 Warner-Lambert Company Reduced alcohol mouthwash antiseptic and antiseptic preparation
US5858370A (en) * 1993-08-20 1999-01-12 Scottish Agricultural College Beneficial effects of plant volatile oils
US5858446A (en) * 1994-09-02 1999-01-12 Byron Australia Pty Ltd Processed fresh herbs and method of making
US5891422A (en) * 1996-10-10 1999-04-06 Warner-Lambert Company Antimicrobial composition containing a C3 -C6 alcohol
US5900230A (en) * 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
US6013304A (en) * 1996-12-13 2000-01-11 Kalamazoo Holdings, Inc. High temperature countercurrent solvent extraction of herb or spice solids
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6027716A (en) * 1997-04-02 2000-02-22 Farmo-Nat Ltd. Synergistic herbal extracts
US6042812A (en) * 1996-11-26 2000-03-28 The Procter & Gamble Company Flavor systems for oral care products
US6169118B1 (en) * 1998-11-12 2001-01-02 Block Drug Company, Inc. Flavor blend for masking unpleasant taste of zinc compounds
US6235318B1 (en) * 1999-01-21 2001-05-22 Charles M. Lombardy, Jr. Effervescent chewing gum
US6235267B1 (en) * 1997-03-31 2001-05-22 Pfizer Inc. Taste masking of phenolics using citrus flavors
US6245309B1 (en) * 1996-12-24 2001-06-12 H2-Tech S.A.R.L Method and devices for producing hydrogen by plasma reformer
US6248343B1 (en) * 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US6248309B1 (en) * 1997-04-04 2001-06-19 Optiva Corporation Gums containing antimicrobial agents
US6338861B1 (en) * 1998-03-26 2002-01-15 Shiseido Company, Ltd. Process of production of natural flavor or fragrance
US6346281B1 (en) * 2000-05-05 2002-02-12 Scentsible Life Products, A Division Of Laid Back Designs Ltd. Antimicrobial composition formulated with essential oils
US6348187B1 (en) * 1996-01-24 2002-02-19 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
US6365209B2 (en) * 2000-06-06 2002-04-02 Capricorn Pharma, Inc. Confectionery compositions and methods of making
US6365130B1 (en) * 1998-11-23 2002-04-02 Agion Technologies L.L.C. Antimicrobial chewing gum
US6379652B1 (en) * 2000-10-16 2002-04-30 Colgate Palmolive Company Oral compositions for reducing mouth odors
US20020081341A1 (en) * 2000-08-31 2002-06-27 Cheryl Sott Method, apparatus, and system for customizing essential oil formulations
US6419903B1 (en) * 2001-08-20 2002-07-16 Colgate Palmolive Company Breath freshening film
US6426085B1 (en) * 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6521216B1 (en) * 1999-11-12 2003-02-18 The Procter & Gamble Company Dual phase stannous oral compositions
US20030068283A1 (en) * 2001-08-24 2003-04-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Composition
US6555094B1 (en) * 1999-11-12 2003-04-29 The Procter & Gamble Company Stannous oral compositions
US6579513B1 (en) * 2002-01-03 2003-06-17 Playtex Products, Inc. Hygiene mouthspray composition
US6585961B1 (en) * 2001-11-30 2003-07-01 Richard F. Stockel Antimicrobial compositions
US6592912B1 (en) * 1997-12-30 2003-07-15 Wm. Wrigley Jr. Company Method of controlling release of antimicrobial agents from chewing gum and gum produced thereby
US20040081713A1 (en) * 2002-06-25 2004-04-29 Maxwell James Roy Breath freshening and oral cleansing product with magnolia bark extract
US6741954B2 (en) * 2000-12-27 2004-05-25 Symrise Gmbh & Co. Kg Selection method for odorants
US20050008732A1 (en) * 2003-07-11 2005-01-13 Petros Gebreselassie Chewing gum and confectionery compositions containing a stain removing complex, and methods of making and using the same
US6855349B2 (en) * 1998-12-07 2005-02-15 Kemin Industries, Inc. Method for simultaneous extraction of essential oils and antioxidants from Labiatae species and the extract products thereof
US6858214B1 (en) * 1999-03-12 2005-02-22 Biotec Asa Use of nanoscalar water-soluble β-(1,3) glucans
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6921539B2 (en) * 2002-02-20 2005-07-26 Dusan Ninkov Antimicrobial therapeutic compositions and method of use
US20050228122A1 (en) * 2004-03-31 2005-10-13 General Electric Company Esteramide compositions, copolymers and blends thereof
US20060013779A1 (en) * 2002-06-25 2006-01-19 Dodds Michael W J Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
US6996919B2 (en) * 2001-03-12 2006-02-14 Bionorica Ag Process for obtaining dry extracts under mild conditions
US7037543B2 (en) * 2000-05-19 2006-05-02 Kalsec, Incorporated Method of extending color life of modified atmosphere packaged fresh red meat using Labiatae plant extracts
US20060120975A1 (en) * 2004-12-02 2006-06-08 Colgate-Palmolive Company Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives
US20060134023A1 (en) * 2004-12-21 2006-06-22 Shira Pilch Oral care malodor composition
US20070031579A1 (en) * 2005-08-04 2007-02-08 Draanen Nanine A V Natural product flavor concentrates as liquid spices: formulation and dispensing
US20070065394A1 (en) * 2003-11-17 2007-03-22 Pinney Virginia R Compositions effective in altering the perception of malodor
US7196117B2 (en) * 2001-11-15 2007-03-27 Laboratorios Miret, S.A. Use of cationic surfactant as activity enhancer in deodorants and oral care
US20070077343A1 (en) * 2005-09-30 2007-04-05 Ma Sheng X Process of concentrating tea and/or herbal aroma and beverages or flavors using the resulting concentrated aroma
US20070082018A1 (en) * 2005-09-28 2007-04-12 Jochen Weiss Stabilized antimicrobial compositions and related methods of preparation
US20070166246A1 (en) * 2004-03-19 2007-07-19 Toyo Shinyaku Co., Ltd. Composition for oral cavity

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB635053A (en) 1945-01-25 1950-04-05 Germinal S A Improvements in or relating to processes for the preparation of extracts from aromatic plants, entirely soluble in hot water
US2571948A (en) 1950-06-28 1951-10-16 Griffith Laboratories Spice extract and method of producing
GB1066391A (en) 1965-04-02 1967-04-26 British American Tobacco Co Improvements relating to extraction processes
BE755397A (en) 1969-10-14 1971-03-01 Int Flavors & Fragrances Inc FLAVORING PROCESS AND PRODUCTS OBTAINED
BE760075A (en) 1970-01-13 1971-06-09 Int Flavors & Fragrances Inc METHODS AND COMPOSITIONS FOR FLAVORING FOODS
US4123559A (en) 1971-06-03 1978-10-31 Studiengesellschaft Kohle Mbh Process for the production of spice extracts
US4045581A (en) 1975-05-15 1977-08-30 Life Savers, Inc. Long-lasting mint-flavored chewing gum
US4217368A (en) 1977-07-08 1980-08-12 Life Savers, Inc. Long-lasting chewing gum and method
DE2747092C2 (en) 1977-10-20 1984-01-05 Württembergische Parfümerie - Fabrik GmbH, 7332 Eislingen Dentifrices containing dyes
US4238510A (en) 1979-02-21 1980-12-09 Life Savers, Inc. Sugarless coating for chewing gum and confections and method
DE2925229B2 (en) 1979-06-22 1981-06-04 Richardson-Merrell GmbH, 6080 Groß-Gerau Process for the production of herb seed candies
US4238475A (en) 1979-08-01 1980-12-09 Life Savers Inc. Chewing cum capable of releasing finely divided water-insoluble materials therefrom
US4490398A (en) 1979-08-02 1984-12-25 Henkel Kommanditgesellschaft Auf Aktien Process for the preparation of spice extracts
US4465661A (en) 1979-11-14 1984-08-14 Basf Wyandotte Corporation Oral product having improved taste
US4301178A (en) 1980-05-02 1981-11-17 Life Savers, Inc. Liquid-filled chewing gum and method
GB2098476B (en) 1981-05-13 1984-10-31 Colgate Palmolive Co Flavoured aqueous oral composition
DE3119454A1 (en) 1981-05-15 1982-12-09 Haarmann & Reimer Gmbh, 3450 Holzminden METHOD FOR THE PRODUCTION OF CONCENTRATED EXTRACTS FROM FRESH PLANTS OR PARTS THEREOF, IN PARTICULAR FRESH KITCHEN HERBS
US4478864A (en) 1982-12-20 1984-10-23 Warner-Lambert Company Confections containing stabilized peppermint oil
US4476142A (en) 1982-12-20 1984-10-09 Warner-Lambert Company Peppermint oil flavored compositions
US4476107A (en) 1983-06-13 1984-10-09 Basf Wyandotte Corporation Mouthwash composition
GB8402641D0 (en) 1984-02-01 1984-03-07 Bush Boake Allen Ltd Perfumery compositions
US4548809A (en) * 1984-03-27 1985-10-22 Fung Paul S T Method for manufacturing a stomatic gargle
US4632937A (en) 1984-12-21 1986-12-30 Ici Americas Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4612205A (en) 1985-04-04 1986-09-16 Procter & Gamble Company Carbonated juice beverage with cola taste
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US4877635A (en) 1985-12-20 1989-10-31 Kalamazoo Holdings, Inc. Herb flavoring and/or antioxidant composition and process
DE3632401A1 (en) 1986-09-24 1988-04-07 Barth Raiser Hopfenextraktion METHOD FOR EXTRACING UNPOLAR INGREDIENTS FROM HOP
US4775537A (en) 1987-04-30 1988-10-04 Warner-Lambert Company Sequentially flavored chewing gum composition
US4835002A (en) 1987-07-10 1989-05-30 Wolf Peter A Microemulsions of oil in water and alcohol
SE461378B (en) 1989-01-16 1990-02-12 Fovarosi Tanacs Gyogyszertari COMPOSITION FOR MEDICAL TREATMENT AND PREVENTION TO PREVENT PARADONTOPATHY
US5063070A (en) 1989-06-30 1991-11-05 Nabisco Brands, Inc. Processes for separation of sterol compounds from fluid mixtures using substantially insoluble compounds
US5064668A (en) 1989-06-30 1991-11-12 Nabisco Brands, Inc. Process for separation of sterol compounds from fluid mixtures
KR920702928A (en) 1989-11-09 1992-12-17 원본미기재 Oral-delivery composition to which flavor is added, and preparation method thereof
US4983394A (en) 1990-05-03 1991-01-08 Warner-Lambert Company Flavor enhancing and medicinal taste masking agent
US5356615A (en) 1991-01-30 1994-10-18 Colgate Palmolive Company Antiplaque oral compositions
US5679389A (en) 1991-07-12 1997-10-21 Warner-Lambert Company Chewing gum compositions having increased flavor and sweetness and methods for preparing same
ES2083190T3 (en) 1991-09-20 1996-04-01 Norac Technologies Inc OLEORRESIN ANTIOXIDANT COMPOSITIONS AND A PROCESS FOR ITS PRODUCTION.
US5853726A (en) 1992-09-16 1998-12-29 Chevereau; Pierre Method for extracting and fixing aromas on non-aqueous substrate, machine for implementing the method, and product thereby
US5338558A (en) 1992-12-09 1994-08-16 Mccormick & Company, Inc. Process for preparing stabilized, partially-dehydrated aromatic plant products
US5437879A (en) 1993-10-04 1995-08-01 Warner-Lambert Company Layered chewing gum confection
US5585343A (en) 1993-11-02 1996-12-17 Givaudan-Roure Corporation Low VOC perfume formulations
CA2143037C (en) 1994-05-02 2002-04-30 Atma Chaudhari Alcohol free mouthwash
ATE229314T1 (en) 1994-07-25 2002-12-15 Warner Lambert Co ANTISEPTIC TOOTHPASTE
US5698181A (en) 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
DE19525026A1 (en) 1995-07-10 1997-01-16 Plantamed Arzneimittel Gmbh Process for the preparation of pharmaceutical preparations with a higher content of essential oils and phenols
US5616358A (en) 1995-07-19 1997-04-01 The Procter & Gamble Company Stable beverages containing emulsion with unweighted oil and process of making
US5702687A (en) 1995-10-03 1997-12-30 Church & Dwight Co., Inc. Chewing gum product with plaque-inhibiting benefits
US5849269A (en) 1996-11-26 1998-12-15 The Procter & Gamble Company Oral compositions containing fluoride, pyrophosphate, peroxide, and nonionic and/or amphoteric surfactants
US5811080A (en) 1996-11-26 1998-09-22 The Procter & Gamble Company Process for increased flavor impact in oral care products
US5820852A (en) 1996-11-26 1998-10-13 The Proctor & Gamble Company Oral compositions containing fluoride, pyrophosphate, and peroxide
US5939050A (en) 1997-04-04 1999-08-17 Optiva Corp. Antimicrobial compositions
GB9707130D0 (en) 1997-04-08 1997-05-28 Advanced Phytonics Ltd Solvent extraction
US5980869A (en) 1997-04-28 1999-11-09 The Procter & Gamble Company Dual phase oral compositions comprising a plant extract from the Ericaceae family
KR20010013377A (en) 1997-06-04 2001-02-26 데이비드 엠 모이어 Mild, leave-on antimicrobial compositions
US5942244A (en) 1997-07-31 1999-08-24 Farmo-Nat Ltd. Local oral herbal slow release tablets
US5948439A (en) 1997-10-31 1999-09-07 Farmo-Nat Ltd. Effervescent granules
US5985345A (en) 1997-12-12 1999-11-16 Kalamazoo Holdings, Inc. High temperature extraction of spices and herbs
AU5726098A (en) 1997-12-30 1999-07-19 Wm. Wrigley Jr. Company Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby
EP1043970A1 (en) 1998-01-06 2000-10-18 The Procter & Gamble Company Antimicrobial peroxy acid oral care compositions and methods
US5965518A (en) 1998-02-23 1999-10-12 Nakatsu; Tetsuo Fragrance compositions having antimicrobial activity
RU2135552C1 (en) 1998-06-10 1999-08-27 Сибирский государственный технологический университет Complex processing of spice-aromatic raw
US5955086A (en) 1998-06-18 1999-09-21 Biotics Research Corporation Oregano for the treatment of internal parasites and protozoa
US6123945A (en) 1998-08-26 2000-09-26 Takasago International Corporation Water-soluble anti-oxidation agents
US6660320B1 (en) 1999-06-25 2003-12-09 University Of Saskatchewan Technologies Inc. Process for producing an antioxidant extract from the bearberry plant
ES2209298T3 (en) 1999-08-18 2004-06-16 SYMRISE GMBH &amp; CO. KG LIBERATION SYSTEM OF AN AROMA.
US7247377B2 (en) 1999-09-17 2007-07-24 Genaro Casas Jassan Absorbent composition of matter for controlled release of essential oils
FR2799660B1 (en) * 1999-10-19 2002-01-18 Hitex SUPERCRITICAL FLUID EXTRACTION PROCESS
US6926916B1 (en) 1999-11-12 2005-08-09 The Procter & Gamble Company Chewing gum compositions
US20010044379A1 (en) 1999-12-10 2001-11-22 Alan Blowers Modification of floral scent in flowering plants
US6322838B1 (en) 2000-04-25 2001-11-27 Haarmann & Reimer Gmbh Mint and/or fruit flavor compositions
US20020025349A1 (en) 2000-05-02 2002-02-28 Brindavanam Narasimha Baba Novel herbal composition for diabetes patients and a process for producing the same
US6315987B1 (en) 2000-05-10 2001-11-13 Isp Investments Inc. Polymeric delivery and release systems for oral care actives
KR100583021B1 (en) 2000-06-14 2006-05-23 퓨아 그린 가부시키가이샤 Oily cosmetics and a process for producing thereof
US6450935B1 (en) 2000-10-13 2002-09-17 Kemin Industries, Inc. Method for removing essential oils and antioxidants from extract products of lamiaceae species using rolled film evaporation
CA2427983C (en) 2000-11-06 2009-06-02 Japan Tobacco Inc. Tobacco odor deodorizing perfume compositon, tobacco odor deodorant, cigarette low in sidestream smoke odor, and tobacco package
US6576285B1 (en) 2000-11-14 2003-06-10 Sunpure Ltd. Cholesterol lowering beverage
US7087255B2 (en) 2000-12-27 2006-08-08 Wm. Wrigley Jr. Company Chewing gums that provide breath freshening characteristics
CN1150924C (en) * 2001-01-20 2004-05-26 广州美晨药业有限公司 Supercritica CO2 extraction and separation method of effective components of curcumae longae rhizome
KR100858768B1 (en) 2001-06-21 2008-09-16 교와 핫꼬 고교 가부시끼가이샤 Process for Producing Plant Extract Containing Plant Powder
RU2199330C1 (en) 2001-08-27 2003-02-27 Галина Петровна Павелковская Method of preparing polyphyto oil
EP1476194A4 (en) 2002-02-19 2005-05-18 Eden Research Plc Compositions and methods for preservation of food
US7595065B2 (en) 2002-06-25 2009-09-29 Wm. Wrigley Jr. Company Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils
US20040013752A1 (en) 2002-07-05 2004-01-22 Wolfson Philip E. Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances
WO2004019802A2 (en) 2002-08-27 2004-03-11 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product using carvacrol
AU2003226617A1 (en) 2003-03-26 2004-10-18 Council Of Scientific And Industrial Research Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis
US20040241186A1 (en) 2003-05-28 2004-12-02 Huang Wentsan G. Aromatherapy formulations and treatment system
US20060246016A1 (en) 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents
US20060159818A1 (en) 2003-07-10 2006-07-20 Takasago International Corporation Flavor enhancer, food or beverage containing the flavor enhancer, and method of flavor enhancement
JP4373280B2 (en) 2003-07-29 2009-11-25 花王株式会社 Lipolysis accelerator
US7879383B2 (en) 2003-12-26 2011-02-01 Council Of Scientific And Industrial Research Rosemary herbal beverage powder and process
US7829067B2 (en) 2004-03-03 2010-11-09 Bio-Botanica, Inc. Method and composition for treating oral bacteria and inflammation
EP1591099A3 (en) 2004-04-28 2005-11-09 MERCK PATENT GmbH Methods for stabilizing ingredients within cosmetics, personal care and household products
US20060024351A1 (en) 2004-07-28 2006-02-02 Diane Bradford Hydrating breath freshening beverage compositions and method therefor
US20090202453A1 (en) 2004-08-03 2009-08-13 Hindustan Lever Limited Oral Composition
US20060264347A1 (en) 2005-05-19 2006-11-23 Xintian Ming Antimicrobial composition
US20070221236A1 (en) 2005-10-05 2007-09-27 Cadbury Adams Usa Llc. Cooling compositions including menthyl esters
US20090018186A1 (en) 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
US20080058418A1 (en) 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
WO2008122286A1 (en) 2007-04-04 2008-10-16 Gumlink A/S Center-filled chewing gum product for dental care
DE102007057258B4 (en) 2007-11-27 2010-09-23 Optisens Gmbh Oil-in-water emulsion for organic food as well as its production and use
US20090214712A1 (en) 2008-02-21 2009-08-27 The Coca Cola Company Milk-Based Beverage and Method for Preventing Off-Flavors in a Milk-Based Beverage
WO2009111685A1 (en) 2008-03-06 2009-09-11 Sensient Flavors Llc Herbal extracts and flavor systems for oral products and methods of making the same
WO2011029077A2 (en) 2009-09-04 2011-03-10 Sensient Flavors Llc Botanical extracts and flavor systems and methods of making and using the same

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821417A (en) * 1970-11-09 1974-06-28 Warner Lambert Co Flavor preservation in chewing gum compositions and candy products
US3746553A (en) * 1971-03-24 1973-07-17 Kraft Sesame Corp Process for cleaning spices and herbs
US4198432A (en) * 1971-06-03 1980-04-15 Studiengesellschaft Kohle Mbh Process for the production of spice extracts
US3947570A (en) * 1972-11-06 1976-03-30 Colgate-Palmolive Company Oral product
US4136065A (en) * 1973-08-06 1979-01-23 Asahi Kasei Kogyo Kabushiki Kaisha Extraction method for odor and flavor producing ingredients of foods and flowers and products produced
US4158708A (en) * 1976-03-09 1979-06-19 Societe D'assistance Technique Pour Produits Nestle S.A. Spice extract
US4157401A (en) * 1978-04-24 1979-06-05 Life Savers, Inc. Chewing gum having improved flavor duration and shelf-life
US4208431A (en) * 1978-05-05 1980-06-17 Life Savers, Inc. Long-lasting chewing gum having good processibility and method
US4318906A (en) * 1979-06-25 1982-03-09 Establissement Rinrone Medicinal composition for external use for treating wounds
US4316915A (en) * 1979-10-01 1982-02-23 Life Savers, Inc. Center-filled chewing gums
US4250196A (en) * 1979-10-09 1981-02-10 Life Savers, Inc. Center-filled chewing gums
US4380506A (en) * 1980-04-08 1983-04-19 Lion Corporation Process for producing preservatives
US4431680A (en) * 1980-08-29 1984-02-14 International Flavors & Fragrances Inc. Process for augmenting or enhancing the aroma or taste of a peppermint oil based oral hygiene flavor by adding thereto methyl substituted oxobicyclo-4,4,0-decane derivatives
US4990329A (en) * 1985-05-24 1991-02-05 The Procter & Gamble Company Composition for treating oral diseases
US5110583A (en) * 1985-05-24 1992-05-05 The Procter & Gamble Company Peroxy acids composition for oral treatment
US4735358A (en) * 1986-03-04 1988-04-05 Daiken Iko Kabushiki Kaisha Method and apparatus of vaporizing active substances
US4925688A (en) * 1986-03-21 1990-05-15 Daniel Voituriez Method of diffusing essential oils and oleo-resins of spices in a carrier solution
US5032387A (en) * 1986-11-06 1991-07-16 Princeton Pharmaceutical Inc. Dental and oral hygiene preparations
US5015464A (en) * 1987-03-25 1991-05-14 Amway Corporation Antiplaque chewing gum
US5023020A (en) * 1987-06-10 1991-06-11 Shimizu Construction Co., Ltd. Method for supplying aromas, apparatus therefore and facilities provided with same
US4923685A (en) * 1987-07-30 1990-05-08 Henkel Kommanditgesellschaft Auf Aktien Antimicrobial flavored compositions having particular utility as mouth washes
US4935104A (en) * 1987-10-19 1990-06-19 Biolandes Process for the continuous hydro-distillation of plants
US4803082A (en) * 1987-10-28 1989-02-07 Warner-Lambert Company Flavor and sweetness enhancement delivery systems and method of preparation
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol
US4923865A (en) * 1988-04-28 1990-05-08 U C B Societe Anonyme Substituted 1-(1H-imidazol-4-yl)alkyl-benzamides as anti-ischemics and as alpha-2-adrenergic receptor agonists
US4985265A (en) * 1988-06-17 1991-01-15 L'air Liquide, Society Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Process for extraction of spices
US4919149A (en) * 1988-07-08 1990-04-24 Stang Michael Andrew Contraception and flavor delivery system
US4994262A (en) * 1988-10-14 1991-02-19 The Procter & Gamble Company Oral compositions
US5110608A (en) * 1988-12-29 1992-05-05 Warner-Lambert Company Chewing gums having longer lasting sweetness
US5093145A (en) * 1989-07-04 1992-03-03 Daregal Process for treating an aromatic plant or herb, or a plant containing essential oils
US5487902A (en) * 1989-07-24 1996-01-30 Fertin Laboratories Ltd. (Dansk Tyggegummi Fabrik A/S) Chewing gum composition with accelerated, controlled release of active agents
US5030459A (en) * 1989-11-07 1991-07-09 Warner-Lambert Company High impact mint flavor for high base chewing gum
US5091117A (en) * 1990-04-16 1992-02-25 Nabisco Brands, Inc. Process for the removal of sterol compounds and saturated fatty acids
US5017397A (en) * 1990-04-25 1991-05-21 Uy Nguyen Process for extracting antioxidants from Labiatae herbs
US5094843A (en) * 1990-09-10 1992-03-10 Beecham Inc. Antimicrobial toothpaste
US5227183A (en) * 1990-12-24 1993-07-13 Mccormick & Company, Inc. Process for preparing dehydrated aromatic plant products and the resulting products
US5525260A (en) * 1991-03-30 1996-06-11 Nestec S.A Preparation of spice extract antioxidant in oil
US5120558A (en) * 1991-05-01 1992-06-09 Norac Technologies Inc. Process for the supercritical extraction and fractionation of spices
US5298238A (en) * 1991-11-07 1994-03-29 Warner-Lambert Company Liquid oral compositions comprising deterpenated and fractionated flavor oils
US5277910A (en) * 1991-12-12 1994-01-11 Mate Hidvegi Process for the preparation of a pharmaceutical composition selectively lowering the blood-lipid level
US5433949A (en) * 1992-03-11 1995-07-18 Skw Trostberg Aktiengesellschaft Process for the production of natural antioxidants
US5723106A (en) * 1993-01-27 1998-03-03 Warner-Lambert Company Reduced alcohol mouthwash antiseptic and antiseptic preparation
US5512285A (en) * 1993-02-22 1996-04-30 Advanced Phytonics Limited Fragrance extraction
US5527552A (en) * 1993-04-01 1996-06-18 Kalamazoo Holdings, Inc. Lipid-soluble green tea catechin antioxidant solutions
US5403587A (en) * 1993-04-22 1995-04-04 Eastman Kodak Company Disinfectant and sanitizing compositions based on essential oils
US5858370A (en) * 1993-08-20 1999-01-12 Scottish Agricultural College Beneficial effects of plant volatile oils
US6426085B1 (en) * 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US20060088481A1 (en) * 1994-05-02 2006-04-27 Athanikar Narayan K Topical oral dosage forms containing bismuth compounds
US5633027A (en) * 1994-08-05 1997-05-27 Fuisz Technologies Ltd. Confectioneries containing stabilized highly odorous flavor component delivery systems
US5858446A (en) * 1994-09-02 1999-01-12 Byron Australia Pty Ltd Processed fresh herbs and method of making
US6348187B1 (en) * 1996-01-24 2002-02-19 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
US5891422A (en) * 1996-10-10 1999-04-06 Warner-Lambert Company Antimicrobial composition containing a C3 -C6 alcohol
US6042812A (en) * 1996-11-26 2000-03-28 The Procter & Gamble Company Flavor systems for oral care products
US6013304A (en) * 1996-12-13 2000-01-11 Kalamazoo Holdings, Inc. High temperature countercurrent solvent extraction of herb or spice solids
US6245309B1 (en) * 1996-12-24 2001-06-12 H2-Tech S.A.R.L Method and devices for producing hydrogen by plasma reformer
US6235267B1 (en) * 1997-03-31 2001-05-22 Pfizer Inc. Taste masking of phenolics using citrus flavors
US6027716A (en) * 1997-04-02 2000-02-22 Farmo-Nat Ltd. Synergistic herbal extracts
US6248309B1 (en) * 1997-04-04 2001-06-19 Optiva Corporation Gums containing antimicrobial agents
US5900230A (en) * 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
US6592912B1 (en) * 1997-12-30 2003-07-15 Wm. Wrigley Jr. Company Method of controlling release of antimicrobial agents from chewing gum and gum produced thereby
US20040067277A1 (en) * 1997-12-30 2004-04-08 Wm. Wrigley Jr. Company Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby
US6248343B1 (en) * 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6338861B1 (en) * 1998-03-26 2002-01-15 Shiseido Company, Ltd. Process of production of natural flavor or fragrance
US6169118B1 (en) * 1998-11-12 2001-01-02 Block Drug Company, Inc. Flavor blend for masking unpleasant taste of zinc compounds
US6365130B1 (en) * 1998-11-23 2002-04-02 Agion Technologies L.L.C. Antimicrobial chewing gum
US6855349B2 (en) * 1998-12-07 2005-02-15 Kemin Industries, Inc. Method for simultaneous extraction of essential oils and antioxidants from Labiatae species and the extract products thereof
US6235318B1 (en) * 1999-01-21 2001-05-22 Charles M. Lombardy, Jr. Effervescent chewing gum
US6858214B1 (en) * 1999-03-12 2005-02-22 Biotec Asa Use of nanoscalar water-soluble β-(1,3) glucans
US6521216B1 (en) * 1999-11-12 2003-02-18 The Procter & Gamble Company Dual phase stannous oral compositions
US6555094B1 (en) * 1999-11-12 2003-04-29 The Procter & Gamble Company Stannous oral compositions
US20020068101A1 (en) * 2000-05-05 2002-06-06 Death S. Samuel Antimicrobial composition formulated with essential oils
US6846498B2 (en) * 2000-05-05 2005-01-25 Scentsible Life Products, A Divison Of Laid Back Designs Ltd. Antimicrobial composition formulated with essential oils
US6346281B1 (en) * 2000-05-05 2002-02-12 Scentsible Life Products, A Division Of Laid Back Designs Ltd. Antimicrobial composition formulated with essential oils
US7037543B2 (en) * 2000-05-19 2006-05-02 Kalsec, Incorporated Method of extending color life of modified atmosphere packaged fresh red meat using Labiatae plant extracts
US6365209B2 (en) * 2000-06-06 2002-04-02 Capricorn Pharma, Inc. Confectionery compositions and methods of making
US20020081341A1 (en) * 2000-08-31 2002-06-27 Cheryl Sott Method, apparatus, and system for customizing essential oil formulations
US6379652B1 (en) * 2000-10-16 2002-04-30 Colgate Palmolive Company Oral compositions for reducing mouth odors
US6741954B2 (en) * 2000-12-27 2004-05-25 Symrise Gmbh & Co. Kg Selection method for odorants
US6996919B2 (en) * 2001-03-12 2006-02-14 Bionorica Ag Process for obtaining dry extracts under mild conditions
US6419903B1 (en) * 2001-08-20 2002-07-16 Colgate Palmolive Company Breath freshening film
US20030068283A1 (en) * 2001-08-24 2003-04-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Composition
US20030077232A1 (en) * 2001-08-24 2003-04-24 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Composition
US7196117B2 (en) * 2001-11-15 2007-03-27 Laboratorios Miret, S.A. Use of cationic surfactant as activity enhancer in deodorants and oral care
US6585961B1 (en) * 2001-11-30 2003-07-01 Richard F. Stockel Antimicrobial compositions
US6579513B1 (en) * 2002-01-03 2003-06-17 Playtex Products, Inc. Hygiene mouthspray composition
US6921539B2 (en) * 2002-02-20 2005-07-26 Dusan Ninkov Antimicrobial therapeutic compositions and method of use
US20060013779A1 (en) * 2002-06-25 2006-01-19 Dodds Michael W J Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
US20040081713A1 (en) * 2002-06-25 2004-04-29 Maxwell James Roy Breath freshening and oral cleansing product with magnolia bark extract
US20050008732A1 (en) * 2003-07-11 2005-01-13 Petros Gebreselassie Chewing gum and confectionery compositions containing a stain removing complex, and methods of making and using the same
US20070077210A1 (en) * 2003-07-11 2007-04-05 Petros Gebreselassie Chewing gum and confectionery compositions containing a stain removing complex, and methods of making and using the same
US20070065394A1 (en) * 2003-11-17 2007-03-22 Pinney Virginia R Compositions effective in altering the perception of malodor
US20070166246A1 (en) * 2004-03-19 2007-07-19 Toyo Shinyaku Co., Ltd. Composition for oral cavity
US20050228122A1 (en) * 2004-03-31 2005-10-13 General Electric Company Esteramide compositions, copolymers and blends thereof
US20060120975A1 (en) * 2004-12-02 2006-06-08 Colgate-Palmolive Company Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives
US20060134023A1 (en) * 2004-12-21 2006-06-22 Shira Pilch Oral care malodor composition
US20070031579A1 (en) * 2005-08-04 2007-02-08 Draanen Nanine A V Natural product flavor concentrates as liquid spices: formulation and dispensing
US20070082018A1 (en) * 2005-09-28 2007-04-12 Jochen Weiss Stabilized antimicrobial compositions and related methods of preparation
US20070077343A1 (en) * 2005-09-30 2007-04-05 Ma Sheng X Process of concentrating tea and/or herbal aroma and beverages or flavors using the resulting concentrated aroma

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11211249B2 (en) 2008-03-06 2021-12-28 Sensient Flavors Llc Herbal extracts and flavor systems for oral products and methods of making the same
WO2011029077A2 (en) 2009-09-04 2011-03-10 Sensient Flavors Llc Botanical extracts and flavor systems and methods of making and using the same
US20110059205A1 (en) * 2009-09-04 2011-03-10 Sylvia Gaysinsky Botanical extracts and flavor systems and methods of making and using the same
EP2544560B1 (en) 2010-03-09 2017-12-20 British American Tobacco (Investments) Limited Methods for extracting and isolating constituents of cellulosic material
US11801209B2 (en) * 2017-12-21 2023-10-31 Firmenich Sa Cooling and flavor boosting compositions
WO2024028179A1 (en) * 2022-08-04 2024-02-08 Juan Antonio Santisteban Ortiz Biocidal composition

Also Published As

Publication number Publication date
WO2009111685A1 (en) 2009-09-11
US11211249B2 (en) 2021-12-28
US20120244084A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
US20140287121A1 (en) Botanical extracts and flavor systems and methods of making and using the same
US11211249B2 (en) Herbal extracts and flavor systems for oral products and methods of making the same
KR101397484B1 (en) Antimicrobially Active Compounds for Treating Bad Breath
US9801919B2 (en) Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
JP5661284B2 (en) Antibacterial flavoring composition
US20090317461A1 (en) Oral compositions effective for the treatment of oral cavity malodor associated with the consumption of odor-causing compounds
JP2008511671A (en) Oral care composition containing essential oils
WO2001012144A1 (en) Gums containing antimicrobial agents
RU2709782C2 (en) Flavouring composition
EP1793796B1 (en) Use of aroma substance mixtures as agents against bad breath
JPWO2005089784A1 (en) Oral composition
US10485746B2 (en) Synergistic antibacterial effects of magnolia bark extract and L-arginine, Nα-lauroyl ethyl ester on salivary bacteria
CN109640935A (en) Mixture comprising (E) -3- benzo [1,3] dioxole -5- base-N, N- diphenyl -2- acrylamide
US20080085246A1 (en) Use of Eugenol Acetate as an Agent Against Bad Breath
AU2016321396B2 (en) Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on plaque biofilm
US20080279791A1 (en) Use of Isoeugenol Methyl Ester as an Agent Against Bad Breath
RU2747506C2 (en) Stable flavoring compositions containing mint leaves
WO2023222577A1 (en) Antimicrobial mixtures
Fitria et al. Bacterial Inhibition Effect of Essential Oil Toothpaste against Dental Plaque of Children with Autism Syndrome Disorder (Asd).
US6391284B1 (en) Nonalcoholic pharmaceutical preparations from formulations including alcohol and process for the preparation thereof
BE1018569A3 (en) METHOD FOR PREPARING A PLANT EXTRACT OF A RHEUM SP. AND USE THIS FOR ORAL CARE.
JPS59227814A (en) Deodorizing composition
US20070212310A1 (en) Antimicrobial smoke flavor for oral microflora control
TW201330863A (en) Liquid activation system

Legal Events

Date Code Title Description
AS Assignment

Owner name: SENSIENT FLAVORS LLC, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUGHES, KENNETH JOHN;GAYSINSKY, SYLVIA;BROWNING, ROGER MICHAEL;REEL/FRAME:022675/0225;SIGNING DATES FROM 20090422 TO 20090510

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION